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1. INTRODUCTION 
Tribbles homolog 3 (TRIB3; also known as TRB3, NIPK, SKIP3 and SINK) is a 
mammalian gene that is strongly activated in response to several forms of cellular 
stress, i.e., environmental conditions that are unfavorable to the cell. Stressors that 
induce TRIB3 expression in diverse cell types include nutrient deficiencies, oxidative 
stress, hypoxia and endoplasmic reticulum (ER) stress—conditions that may occur to 
a certain degree in normal physiology but which also contribute to the pathology of 
several common diseases, including cancer, stroke and myocardial infarction. 
The protein encoded by TRIB3 contains a single distinct domain, which dis-
plays sequence similarity to the protein kinase domain. However, several amino 
acid residues which are highly conserved in catalytically active protein kinases, 
and are considered to be important for the functioning of these enzymes, have 
been substituted in the TRIB3 kinase-like domain. Due to this, TRIB3 is classi-
fied as a pseudokinase and significant phosphotransferase activity is considered 
unlikely. As such, TRIB3 functions by forming protein–protein interactions and 
thereby regulating the activity of other proteins, including several transcription 
factors, protein kinases and ubiquitin ligases. Through such interactions, TRIB3 
participates in the regulation of the cellular stress response and has the potential 
to affect cell survival. Additionally, TRIB3 is also implicated in developmental pro-
cesses, inflammation and metabolism. The known mechanisms of TRIB3 regulation 
and function are the focus of the literature overview presented in this dissertation. 
Through the work done previously by our group and others, TRIB3 has 
emerged as an exciting gene with the potential to participate in multiple facets 
of mammalian biology. For the experimental part of this dissertation, several 
novel aspects of the role and regulation of the TRIB3 gene were studied at the 
cell and organism levels, facilitated by the generation of a Trib3 knockout 
mouse line by our group.  
To acquire a better understanding of TRIB3 upregulation in response to stress, 
comparative quantification of different TRIB3 mRNA isoforms was performed in 
human hepatoma cells, revealing that the mRNA population composition shifts 
markedly in stressed cells. Studying the role of mouse Trib3 in in vitro-
differentiated mast cells, a type of tissue-resident immune cell, uncovered a growth 
factor-sensitive manner of Trib3 expression in these cells as well as links between 
Trib3 and cellular immunological responses. In the brain, cellular stress response 
pathways are known to mediate cognitive processes as part of normal physiology, 
which prompted the analysis of Trib3 expression in the developing and adult mouse 
brain and the characterization of the behavioral phenotype of mice that lack Trib3. 
Finally, the role of TRIB3 in the cellular stress response to glucose deficiency was 
investigated in cell culture, identifying TRIB3-modulated genes using genome-
wide gene expression profiling and leading to new insight into the regulation of cell 
survival in nutrient-poor conditions.  
Taken together, the results signify that TRIB3, a single-domain protein with 
impaired catalytic activity, performs a complex of roles, many of which are 
likely to be cell type-specific. 
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2. REVIEW OF LITERATURE 
2.1. The discovery of Drosophila Tribbles and mammalian TRIB3 
In the world of science fiction, tribbles first appeared on December 29, 1967, 
when the Star Trek: The Original Series episode entitled “The Trouble with 
Tribbles” was originally aired in the United States (Okuda and Okuda, 1997). 
Central to the plot of this episode are tribbles, a species of alien organisms that 
are depicted as small, round, furry and soft, and are thus adored by the crew of 
the spaceship and introduced onboard as pets. However, as tribbles proliferate 
unbelievably quickly and prove hard to contain, they soon threaten to consume 
all the supplies available on the ship. Eventually, tribbles manage to enter the 
cargo hold, which is filled with grain that the ship is on a mission to transport, 
and proceed to consume the cargo. Unexpectedly, when the crew discovers that 
the grain has been consumed, they also notice that the tribbles are dying as a 
result of this, revealing to the crew that the cargo they had been transporting 
was poisoned all along. 
Tribbles were linked to the world of biology in the year 2000, when several 
investigators reported on a previously uncharacterized Drosophila melanogaster 
(fruit fly) gene (Grosshans and Wieschaus, 2000; Mata et al., 2000; Rorth et al., 
2000; Seher and Leptin, 2000). In mutant embryos deficient of this gene, a 
profound over-proliferation of mesodermal cells was evident during the 
gastrulation phase, and it was this observation that led Seher and Leptin to name 
the novel gene tribbles, after the uncontrollably proliferating alien species from 
the Star Trek television series (Seher and Leptin, 2000). In Drosophila, 
Tribbles, the protein encoded by the tribbles gene, inhibits mitosis during early 
embryonic development by binding to and inducing the ubiquitination of the 
phosphatase String, an ortholog of mammalian cell division cycle 25 (CDC25), 
subsequently leading to proteasomal degradation of String and cell cycle arrest 
in the G2 phase (Grosshans and Wieschaus, 2000; Mata et al., 2000; Seher and 
Leptin, 2000). 
In mammals, there are three genes that are considered to encode homologs of 
Drosophila Tribbles (TRIB1, TRIB2 and TRIB3), and their discoveries actually 
precede that of the fruit fly tribbles gene which they were eventually named 
after. In 1996, TRIB2 (originally designated c5fw) was isolated from a thyroid 
cDNA library, followed by TRIB1 (originally designated c8fw) in 1997, also 
from thyroid tissue (Wilkin et al., 1996; Wilkin et al., 1997). TRIB3 was first 
described as neuronal cell death-inducible putative kinase (NIPK), a gene that 
was strongly upregulated in rat neuronal cells during programmed cell death 
brought on by nerve growth factor deprivation or treatment with the calcium 
ionophore A23187 (Mayumi-Matsuda et al., 1999). Independently, the mouse 
gene corresponding to TRIB3 was first isolated by our group, using differential 
cloning to search for genes that are upregulated in neuronal GT1-7 cells during 
apoptotic cell death induced by treatment with thapsigargin, an inhibitor  
of ATP-dependent calcium uptake into the ER (Örd and Örd, 2003).  
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At approximately the same time, the human TRIB3 gene was described by 
several groups who designated it either SKIP3 (stress kinase inhibitory protein 
3), SINK (p65-interacting inhibitor of NF-κB) or TRB3 (tribbles homolog 3) 
(Bowers et al., 2003; Du et al., 2003; Kiss-Toth et al., 2004; Wu et al., 2003). 
Recently, the organization responsible for approving human gene names, the 
HUGO Gene Nomenclature Committee, has redefined the meaning of TRIB3 to 
“tribbles pseudokinase 3”, instead of its previously approved definition, “trib-
bles homolog 3 (Drosophila)” (data available at: www.genenames.org, accessed 
2016-01-29). On the other hand, the organization that provides official names 
for mouse genes, the Mouse Genomic Nomenclature Committee, currently 
continues to define Trib3, the mouse ortholog of human TRIB3, as “tribbles 
homolog 3 (Drosophila)” (data available at: www.informatics.jax.org/mgihome/ 
nomen, accessed 2016-01-29). According to the official nomenclatures for 
human and mouse genes (referenced above), the proteins that are produced from 
mouse Trib3 and human TRIB3 are both referred to as TRIB3. 
 
 
 2.2. The structure of the TRIB3 protein 
2.2.1. The peculiar kinase-like domain of Tribbles family proteins 
The characteristic feature of Drosophila as well as vertebrate Tribbles proteins 
is a central domain that possesses sequence similarity to the serine/threonine 
protein kinase domain but contains several amino acid substitutions at catalyti-
cally important positions, leading to the classification of Tribbles proteins as 
pseudokinases (Boudeau et al., 2006; Hegedus et al., 2006; Hegedus et al., 
2007). The kinase-like domain, which is approximately 250–300 amino acid 
residues in length, comprises the majority of the protein, and it is flanked by 
less-conserved, short (approximately 40–80 amino acid residues long) N- and 
C-terminal regions (Figure 1) (Hegedus et al., 2006; Hegedus et al., 2007). 
Human and mouse TRIB3 proteins, at 358 and 354 amino acid residues in 
length, respectively, correspond to the typical Tribbles family protein structure, 
and their predicted molecular weights are approximately 40 and 39 kDa, 
respectively (Bowers et al., 2003; Örd and Örd, 2003). 
 
 
2.2.1.1. The state of catalytic motifs in the Tribbles pseudokinase domain 
Close to ten percent of the more than 500 protein kinases encoded in the human 
genome are considered pseudokinases due to the lack of one or more conserved 
amino acid motifs that are critical for the catalytic activity of ‘classical’ protein 
kinase domains (Boudeau et al., 2006; Manning et al., 2002). Pseudokinases 
exist among many different protein kinase subfamilies and different 
pseudokinases feature distinct sets of alterations to the canonical catalytically 
important residues (Boudeau et al., 2006). In the region corresponding to the 
ATP binding site in classical protein kinases, Tribbles proteins lack a canonical
  
Figure 1. Comparison of the amino acid sequences of the three human (h) Tribbles homolog 
pseudokinases (hTRIB3, hTRIB2 and hTRIB1), the mouse (m) ortholog of hTRIB3, and 
hMELK, the most hTRIB3-similar human kinase with canonical catalytic motifs and robust 
protein kinase activity. Of the typical protein kinase domain motifs, the putative ATP binding 
region of TRIB proteins lacks a canonical glycine-rich loop but does contain the conserved lysine 
residue in the VAIK motif. In the catalytic loop (the HRD motif), the catalytic aspartic acid residue 
is present but the histidine residue has been substituted. The DFG motif, which binds Mg2+ ions in 
canonical kinases, is completely absent in TRIB proteins. For hTRIB1, crystal structure analysis 
has revealed a loop with the sequence PLAEREH in place of the glycine-rich loop of canonical 
kinases (3D structures for other TRIB proteins are not available). Outside of the kinase-like 
domain, a motif with the amino acid sequence [D/E]QXVP[D/E] can be identified in the  
C-terminal region of TRIB proteins; this motif has been found to mediate binding to the E3 
ubiquitin ligase COP1. For references, see main text. The protein sequences were obtained from 
UniProt entries Q96RU7 (hTRIB3), Q8K4K2 (mTRIB3), Q92519 (hTRIB2), Q96RU8 (hTRIB1) 
and Q14680 (hMELK) (data available at: www.uniprot.org, accessed 2016-01-29; UniProt 
Consortium, 2015). For hMELK, only the region extending from the N-terminus to the end of the 
kinase domain is included (amino acid residues 1–263). The extent of the protein kinase-(like) 
domains was determined based on PROSITE (available at: prosite.expasy.org, accessed 2016-01-
29, database version 20.122; Sigrist et al., 2013). The sequences were aligned using the T-Coffee 
multiple sequence alignment tool (available at: www.ebi.ac.uk/tools/msa/tcoffee, accessed 2016-
02-01, version 8.93, BLOSUM matrix; Notredame et al., 2000). The alignment was visualized with 
BioEdit (version 7.0.9.0; Hall, 1999). COP1, constitutive photomorphogenesis protein 1 homolog; 
MELK, maternal embryonic leucine zipper kinase. 
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glycine-rich loop, while the highly conserved lysine residue in the VAIK motif 
is generally present (Boudeau et al., 2006; Hanks and Hunter, 1995; Hegedus et 
al., 2007). In the region that corresponds to the catalytic loop, the catalytic 
aspartic acid residue from the HRD motif is conserved in Tribbles proteins; 
however, the nearly-invariant histidine residue in the catalytic core HRD motif 
is not conserved (Hanks and Hunter, 1995; Hegedus et al., 2006). Finally, 
Tribbles proteins lack the conserved DFG motif that is required for binding 
Mg2+ in canonical protein kinases (Hanks and Hunter, 1995; Hegedus et al., 
2007). 
 
 
2.2.1.2. Scrutinizing the (lack of) kinase activity in Tribbles proteins 
Due to the striking deviations from canonical protein kinase structure (described 
in the previous section), Tribbles proteins have been predicted to be catalyti-
cally inactive, and, in agreement with this, in vitro experiments designed to 
detect the phosphorylation of classical non-specific kinase substrate proteins by 
TRIB3 or TRIB2 have been unable to demonstrate phosphotransferase activity 
(Bowers et al., 2003; Wilkin et al., 1997). 
In light of this, a recent report by Bailey et al. (2015) showing that human 
TRIB3 and TRIB2 possess the ability to auto-phosphorylate in vitro, albeit very 
weakly, is of considerable interest. Such a revelation is not without precedent 
among pseudokinases, as there have been several cases where proteins with 
kinase-like domains were initially predicted to lack kinase activity, due to 
missing catalytic motifs, but were subsequently shown to be functional protein 
kinases (examples include WNK1, CASK and HER3) (Boudeau et al., 2006; 
Mukherjee et al., 2008; Shi et al., 2010; Xu et al., 2000). In these cases, the 
phosphorylation reaction often proceeds by non-standard catalytic mechanisms. 
For example, in the WNK (‘with no lysine’) kinases, the VAIK motif of the 
ATP binding pocket lacks the canonical lysine residue, and a lysine residue 
from a different strand is found in the active site (Min et al., 2004; Xu et al., 
2000). Similarly to the Tribbles proteins, the protein kinase CASK lacks the 
canonical metal-binding aspartic acid residue in the DFG motif; however, 
CASK was eventually found to function as a Mg2+-independent kinase, 
demonstrating that Mg2+ binding is not indispensable for kinase activity 
(Mukherjee et al., 2008).  
For TRIB3 and TRIB2, it was shown that the ability to auto-phosphorylate 
requires the conserved lysine residue of the VAIK motif in the ATP binding 
site, and that this auto-phosphorylation only occurs in the absence of divalent 
metal cations (Bailey et al., 2015). Further experiments with TRIB2 confirmed 
that it binds ATP with an affinity that could be physiologically relevant, and, in 
line with the auto-phosphorylation results, the binding of ATP occurs in a 
manner dependent on the conserved lysine residue of the ATP binding pocket 
(Bailey et al., 2015). In contrast, human TRIB1 was found to be unable to bind 
ATP in vitro, irrespective of the presence or absence of Mg2+ (Murphy et al., 
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2015). Therefore, it is possible that the family-wide systematic presence and 
conservation of unusual kinase domain motif variants represents enzymatic 
adaptations of Tribbles proteins, but the enzymatic capabilities probably do not 
manifest in all family members. As of now, the significance of TRIB3 and 
TRIB2 kinase activity remains uncertain, as only a very low level of phos-
photransferase activity has been demonstrated under particular in vitro condi-
tions, and the biological function of this activity has not been elucidated, nor 
have any cellular substrates been identified (Bailey et al., 2015). 
 
 
2.2.1.3. Insights into Tribbles pseudokinase  
domain geometry from the first 3D structure 
In late 2015, the crystal structure of human TRIB1 (without its N-terminal 
region) was published, representing the first experimental three-dimensional 
structure available for any member of the Tribbles family (Murphy et al., 2015). 
In general, the structure of a protein kinase domain is made up of an N-terminal 
lobe that comprises the binding site for ATP, and a C-terminal lobe that is 
considered to be mainly responsible for binding the peptide substrate (Hanks 
and Hunter, 1995). In the structure of the TRIB1 kinase-like domain, the C-
terminal lobe was found to adopt a conformation akin to that of canonical 
kinases, while the structure of the N-terminal lobe deviated considerably from 
that of conventional kinases, resulting in a deformed ATP binding pocket that 
appears to preclude nucleotide binding (Murphy et al., 2015). Thus, the TRIB1 
active site geometry is in agreement with the lack of ATP binding ability 
observed experimentally for TRIB1 (Murphy et al., 2015). Since TRIB2 and 
TRIB3 present (weak) ATP binding/auto-phosphorylation abilities, differences 
in their amino acid sequences compared to TRIB1 presumably lead to structural 
rearrangements in the ATP binding region, substituting or relocating occluding 
residues (Bailey et al., 2015; Eyers, 2015; Murphy et al., 2015). 
 
 
2.2.2. The N- and C-terminal regions of Tribbles family proteins 
Outside of the kinase-like domain, the N-terminal segment in Tribbles family 
proteins is characterized by high serine and proline content, and could serve as a 
PEST (proline, glutamic acid, serine and threonine-enriched) region, an element 
that reduces the intracellular half-life of a protein by promoting its degradation 
(Hegedus et al., 2007). The half-life of the TRIB3 protein can indeed be very 
short in certain conditions, even as short as 15 minutes (Ohoka et al., 2010) or a 
few hours (Humphrey et al., 2010; Zhou et al., 2008b), due to the degradation 
of TRIB3 by the ubiquitin–proteasome system. However, in different condi-
tions, the half-life of TRIB3 protein has been determined to be approximately 
10 hours or more (Liew et al., 2010; Wennemers et al., 2012); thus, the turnover 
rate of TRIB3 protein is strongly context-dependent. 
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Additionally, the N-terminal regions of TRIB3 and TRIB1 contain a func-
tional nuclear localization signal, while the TRIB2 protein contains no apparent 
nuclear localization signal (Kiss-Toth et al., 2006). In line with this, TRIB3 and 
TRIB1 are readily imported into the nucleus (Kiss-Toth et al., 2006; Örd and 
Örd, 2003; Wu et al., 2003; Yokoyama et al., 2010), while TRIB2 is generally 
not nuclear (Kiss-Toth et al., 2006; Wang et al., 2013a; Wilkin et al., 1997), 
although the presence of TRIB2 in the nucleus has also been reported (Wang et 
al., 2013b). Although TRIB3 is often predominantly localized to the nucleus, 
major roles for TRIB3 (discussed subsequently) have been reported in both the 
nucleus and the cytoplasm. 
The C-terminal segments of the Tribbles family proteins contain two 
conserved motifs (Hegedus et al., 2006; Hegedus et al., 2007; Yokoyama and 
Nakamura, 2011), and the functional significance of these motifs has been 
elucidated. The motif with the consensus sequence ILLHPWF is the binding 
site for MEK1, a mitogen-activated protein kinase kinase (MAPKK) 
(Yokoyama et al., 2010; Yokoyama and Nakamura, 2011), while the motif 
[D/E]QXVP[D/E] serves as the binding site for the E3 ubiquitin ligase COP1, 
which is recruited by Tribbles proteins to mediate proteasomal destruction of 
target proteins (Keeshan et al., 2010; Qi et al., 2006). 
 
 
2.2.3. How distinct is TRIB3 in terms of protein sequence? 
Beyond the short N- and C-terminal motifs described above, sequence conser-
vation amongst the Tribbles family, and between the Tribbles family proteins 
and other proteins, is mostly limited to the kinase-like domain (Hegedus et al., 
2006). The sequence of the kinase-like domain of human TRIB3 is 55% 
identical to that of human TRIB2, 54% identical with human TRIB1, and 45% 
identical to the kinase-like domain of Drosophila Tribbles (Örd, 2008), 
indicating considerable intra-family divergence. Notably, TRIB1 and TRIB2 are 
substantially more similar to each other (71% sequence identity in humans) than 
to TRIB3 (comparisons mentioned above) (Yokoyama and Nakamura, 2011). 
Comparing the kinase-like domains of Tribbles homologs in human and mouse, 
TRIB3 appears to be relatively less conserved than the other Tribbles family 
members, with murine TRIB3 demonstrating 81% sequence identity to human 
TRIB3, while for TRIB1 and TRIB2 the level of sequence identity between 
human and mouse is greater than 97% (Yokoyama and Nakamura, 2011). Less 
stringent between-species conservation of TRIB3, compared to TRIB1 and 
TRIB2, appears to be a general trend among mammals, as indicated by the 
phylogenetic tree of Tribbles-like sequences generated by Hegedus et al. 
(2006).  
Excluding the other Tribbles homologs, the human protein most similar to 
human TRIB3 is STK40 (‘serine/threonine kinase 40’, also known as SgK495 
and SHIK), which has a kinase-like domain with 37% sequence identity to that 
of TRIB3, and is also a pseudokinase (Bailey et al., 2015; Boudeau et al., 2006; 
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Huang et al., 2003). Curiously, the set of canonical catalytic motifs that are 
either missing or present in the STK40 kinase-like domain is similar to that of 
the Tribbles proteins; however, the kinase-like domain of STK40 is considered 
severely degraded due to insertions and substitutions, and STK40 has failed to 
show auto-phosphorylation ability in vitro (Bailey et al., 2015).  
Following STK40, the next most similar human kinases compared to TRIB3 
are several kinases from the calcium/calmodulin-dependent protein kinase 
family. Among these, the human TRIB3 kinase-like domain has the highest 
degree of identity, 30%, with the kinase domain of maternal embryonic leucine 
zipper kinase (MELK), a catalytically active kinase with canonical catalytic 
motifs (Gil et al., 1997). Several crystal structures of human MELK have 
recently been made available in the Protein Data Bank (the earliest structure 
being PDB ID: 4BL1, contributed by Canevari et al., unpublished in literature 
as of 2016-01-12). Thus, MELK is also the most TRIB3-similar active kinase 
that has a three-dimensional structure available. 
 
 
2.2.4. Post-translational modifications of TRIB3 
A number of post-translational modifications of the TRIB3 protein are known to 
occur (summarized in Table 1), acting alongside other mechanisms to regulate 
TRIB3 gene output. 
According to the PhosphoSitePlus database (available at: www.phosphosite.org, 
accessed 2015-10-19; Hornbeck et al., 2012), a total of five phosphorylation sites 
(four in human, one in mouse) have been observed for TRIB3 so far. However, 
each of these modification sites has only been reported in a one study, and all of 
these studies are high-throughput proteomic analyses using mass spectrometry 
(Hornbeck et al., 2012; Mertins et al., 2013; Rinschen et al., 2010; Zhou et al., 
2013b). Furthermore, no kinases have been associated with these putative 
phosphorylation events, nor has functional significance been assigned to 
these modifications. As described in section 2.2.1.2, TRIB3 demonstrates a 
low level of auto-phosphorylation in vitro. However, the modification site(s) 
and the functional importance of this activity have not been elucidated 
(Bailey et al., 2015). Taken together, the phosphorylation of TRIB3 
probably does occur in vivo, but the details of this modification are currently 
uncertain. 
Other post-translational modifications of TRIB3 include ubiquitination 
(Ohoka et al., 2010; Zhou et al., 2008b), methylation (Rasmussen et al., 2015) 
and acetylation (Yao and Nyomba, 2008). The ubiquitination of TRIB3 leads to 
the proteasome-mediated degradation of TRIB3 and has been reported to take 
place via a direct protein–protein interaction with the E3 ubiquitin ligase SIAH1 
(Zhou et al., 2008b) as well as by physical interaction with CDH1 and CDC20, 
co-activators of the E3 ubiquitin ligase APC/C (‘anaphase-promoting 
complex/cyclosome’) (Ohoka et al., 2010). TRIB3 is lysine-methylated by 
SMYD1, a histone methyltransferase for which TRIB3 is a non-histone 
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substrate (Rasmussen et al., 2015). Acetylation of TRIB3 has been reported in 
the rat liver, and prenatal alcohol exposure leads to the hypo-acetylation of 
TRIB3 (Yao and Nyomba, 2008). 
A post-translational truncation of human TRIB3 occurs when it is cleaved by 
caspases at position D338, resulting in the elimination of a C-terminal fragment 
that is twenty amino acid residues in length (Shimizu et al., 2012). Several 
caspases (caspase-3, -6, -7, -8, -9 and -10), have been shown to perform the 
cleavage of TRIB3 at D338, and they utilize only this site to cleave TRIB3 
(additionally, caspase-2 cleaves at D343 and/or D351) (Shimizu et al., 2012). 
The caspase-mediated cleavage of TRIB3 has been proposed to regulate the 
activation of apoptotic processes (Shimizu et al., 2012), as will be discussed 
subsequently. 
 
 
Table 1. Post-translational modifications that have been described for TRIB3. 
Modification Result of modification Reference(s) 
Acetylation • Reduced TRIB3 acetylation is associated 
with insulin resistance 
Yao and Nyomba 
(2008) 
Methylation • Potentiation of SMYD1-mediated 
repression of transcription 
Rasmussen et al. 
(2015) 
Phosphorylation • Significance currently unknown Bailey et al. (2015) 
Proteolytic 
cleavage 
• Caspase-mediated site-specific truncation of 
TRIB3 protein at the C-terminal end; 
regulation of apoptosis 
Shimizu et al. 
(2012) 
Ubiquitination • Proteasomal degradation of TRIB3 protein Ohoka et al. (2010); 
Zhou et al. (2008b) 
 
 
 
2.3. The regulation of TRIB3 gene expression 
2.3.1. The tissue distribution of TRIB3 mRNA expression 
In a healthy adult mouse, Trib3 mRNA is expressed in a variety of tissues.  
A high level of expression is consistently detected in the liver, and substantial 
levels of expression have also been reported (with some inconsistencies 
between studies) in the small intestine, stomach, heart, kidney, lung, skin, 
brown adipose tissue, white adipose tissue, cerebellum, salivary gland, bone, 
pancreas, placenta and eye, while the level of Trib3 mRNA expression tends be 
low in skeletal muscle, forebrain, spleen, thymus, ovary, uterus and testis 
(Lattin et al., 2008; Okamoto et al., 2007; Örd and Örd, 2003; Pontius et al., 
2003; Wu et al., 2009). Comparing the tissue expression patterns of the three 
Tribbles homologs present in the mouse, there is some overlap between the 
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genes as well as some apparent differences. For instance, all three Tribbles 
homologs are expressed in the mouse heart, kidney, lung, adipose tissue and 
skin (Okamoto et al., 2007). The liver, a major site of Trib3 expression, is also a 
major site of Trib1 (but not Trib2) expression (Okamoto et al., 2007). On the 
other hand, the small intestine and stomach are relatively major sites of Trib3 
expression, but this is not the case for Trib1 or Trib2 (Okamoto et al., 2007). 
In line with the results from mouse, human multi-tissue mRNA panels 
consistently confirm that TRIB3 expression is high in the liver, compared to 
many other tissues (Bowers et al., 2003; Wu et al., 2003). In broad terms, the 
tissue expression profile of human TRIB3 resembles that of mouse Trib3, 
although there are some notable differences that appear across multiple studies, 
such as relatively low expression in the human heart and high expression in the 
human spleen and thymus (Bowers et al., 2003; Kiss-Toth et al., 2004; Pontius et 
al., 2003; Uhlen et al., 2015; Wu et al., 2003). Additionally, human tissue profiling 
also highlights the thyroid gland, bone marrow and peripheral blood leukocytes as 
sites of high TRIB3 mRNA expression (Kiss-Toth et al., 2004; Uhlen et al., 2015). 
It would also be of interest to compare the abundance of TRIB3 protein 
across different tissues or cells; unfortunately, such data is scarce. The Human 
Protein Atlas project has performed immunohistochemical analysis of TRIB3 
using an extensive panel of tissues; however, the reliability of this data is cate-
gorized as ‘uncertain’, since their in-house antibody validation procedure 
revealed issues with the anti-TRIB3 antibody that was used (product name: 
HPA015272, data available at: www.proteinatlas.org, accessed 2015-10-19; 
Uhlen et al., 2015). Problems with the specificity and sensitivity of antibodies 
that are available against TRIB3 have also been documented by others (for 
example, Wennemers et al., 2011b). 
 
 
2.3.2. TRIB3 expression is induced in  
response to diverse types of cellular stress 
A major feature of TRIB3 gene expression is the upregulation of the TRIB3 
mRNA level in response to diverse types of cellular stress. For example, TRIB3 
is induced in cells suffering from ER stress (the accumulation of unfolded pro-
teins in the ER lumen), oxidative stress (an excess of reactive oxygen species) 
or hypoxia (inadequate oxygen supply) (Bowers et al., 2003; Lange et al., 2008; 
Mayumi-Matsuda et al., 1999; Morse et al., 2010; Ohoka et al., 2005; Örd and 
Örd, 2003; Wennemers et al., 2011a). Essential amino acid deficiency, which 
impairs protein synthesis, is also known to lead to the upregulation of TRIB3 
(Carraro et al., 2010; Jousse et al., 2007; Örd et al., 2007). Other nutritional 
stressors that activate TRIB3 include free fatty acids (including saturated fatty 
acids, e.g., palmitic acid, and polyunsaturated fatty acids, e.g., docosahexaenoic 
acid) and glucose deficiency as well as excess (Geng et al., 2013; Liu et al., 
2010; Morse et al., 2010; Qian et al., 2008; Schwarzer et al., 2006; Shaikh et 
al., 2008; Slagsvold et al., 2010; Yacoub Wasef et al., 2006). 
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Various chemical toxicants, such as arsenite, carbon tetrachloride and 
cadmium, also increase the level of TRIB3 mRNA expression (Campos et al., 
2014; Hsiao and Stapleton, 2009; Örd and Örd, 2005; Permenter et al., 2011; 
Wu et al., 2003), as do ionizing radiation (Kim et al., 2014a) and viral infection 
(Liao et al., 2013; Yamane et al., 2009). Extracellular signals, such as the pro-
inflammatory cytokine tumor necrosis factor (TNF) or the depletion of nerve 
growth factor, and even mechanical stretch, can also elevate TRIB3 expression 
(Cheng et al., 2015; Mayumi-Matsuda et al., 1999; Wu et al., 2003).  
Furthermore, TRIB3 is induced in response to several drugs that are currently 
approved or being investigated as anti-cancer therapeutics, for example, the 
proteasome inhibitor bortezomib, the multikinase inhibitor sorafenib, the 
nuclear factor-κB (NF-κB) inhibitor DHMEQ, the cannabinoid tetrahydro-
cannabinol, the nonsteroidal anti-inflammatory drug celecoxib, the peroxisome 
proliferator-activated receptor α/γ (PPARα/γ) activator ABTL0812, and 
salinomycin, a novel anti-cancer compound with an uncertain mechanism of 
action (Cervello et al., 2013; Cusimano et al., 2010; Erazo et al., 2015; 
Lampiasi et al., 2009; Li et al., 2013; Locatelli et al., 2013; Milani et al., 2009; 
Salazar et al., 2009b; Vara et al., 2011). Notably, genotoxic stress (induced 
either by the DNA intercalating agent doxorubicin or the topoisomerase 
inhibitor etoposide) does not appear to increase TRIB3 expression (Corcoran et 
al., 2005; Sakai et al., 2010). 
Taken together, there is an extensive body of literature showing that the level 
of TRIB3 mRNA expression is subject to upregulation in a wide range of mech-
anistically distinct stress conditions. 
 
 
2.3.3. The basis of cellular stress-induced TRIB3 gene activation 
2.3.3.1. The TRIB3 gene contains a C/EBP–ATF composite site 
The human TRIB3 gene is located in the short arm of chromosome 20, at bands 
p13–p12.2, and spans approximately 17 kbp (NCBI Gene ID: 57761). The 
human TRIB3 and mouse Trib3 (NCBI Gene ID: 228775) genes have a similar 
structure. The first exon encompasses the entire 5′-untranslated region (5′-UTR) 
of the mRNA and thus the very first nucleotides of the second exon constitute 
the translation initiation codon. The second and third exons are entirely protein-
coding, and the protein-coding region, which is approximately 1100 nt long in 
total, ends in the fourth and final exon. The stop codon is followed by a 3′-UTR 
which is close to 1 kb in length.  
Several regulatory elements have been identified in the TRIB3 gene. The 
transcription regulation element which mediates the induction of TRIB3 in response 
to many types of cellular stress is termed a C/EBP–ATF composite site, and it is 
located approximately one hundred base pairs upstream of frequently used 
transcription start sites in the human TRIB3 gene (Ohoka et al., 2005; Örd and Örd, 
2005). In addition to human TRIB3, the C/EBP–ATF site has been determined to be 
conserved and functional in the mouse Trib3 gene as well (Carraro et al., 2010). 
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C/EBP–ATF composite sites are binding sites for basic region–leucine 
zipper (bZIP) transcription factor heterodimers consisting of a CCAAT/ 
enhancer-binding protein (C/EBP) family transcription factor and an activating 
transcription factor (ATF) family transcription factor, and the consensus 
sequence of C/EBP–ATF sites (5′-NTTNCATCA-3′) is, accordingly, composed 
of half-sites for each family (Kilberg et al., 2009). During cellular stress, 
C/EBP–ATF sites typically serve as positive (transcription-activating) 
regulatory elements, and they satisfy the criteria for classification as enhancer 
elements, since they function in an orientation- and position-independent 
manner (Han et al., 2013; Kilberg et al., 2009; Palii et al., 2004; Zhong et al., 
2003). 
Intriguingly, the C/EBP–ATF element of the human TRIB3 gene is located 
on a 33-bp tandem repeat, with the regulatory element situated approximately in 
the center of the repeating sequence (Ohoka et al., 2005; Örd and Örd, 2005). 
The copy number of this repeat is polymorphic in the human population, with a 
range of 2–5 copies, and all of the four reported alleles appear to be quite prev-
alent (Liew et al., 2010; Örd and Örd, 2005). In a reporter assay using a 
heterologous promoter construct containing either three or six copies of the 
TRIB3 33-bp repeat, the doubling of the repeat copy number entailed an 
approximately two-fold increase in reporter gene activity in both basal and 
cellular stress conditions (Chaveroux et al., 2015), indicating that the copy 
number of the repeat may be positively associated with the level of TRIB3 
expression. However, it is currently unexplored whether the natural copy 
number variation of the TRIB3 33-bp repeat affects TRIB3 levels in the human 
population. 
 
 
2.3.3.2. ATF4 and the ‘integrated stress response’:  
driving transcription from C/EBP‒ATF sites  
as a result of eIF2α phosphorylation 
The transcription factor ATF4 serves as the master regulator of transcription 
induction from C/EBP–ATF response elements, and, during cellular stress, 
ATF4 directly binds to and activates the expression of at least around two 
hundred genes via these elements (Han et al., 2013; Shan et al., 2009). 
ATF4 is the central transcriptional regulator of the integrated stress response 
pathway, wherein ATF4 is induced by a translational mechanism in response to 
the phosphorylation of the eukaryotic translation initiation factor 2α (eIF2α) at 
serine 51 (Harding et al., 2003; Lu et al., 2004). In mammalian cells, the phos-
phorylation of eIF2α may be carried out by four kinases (GCN2, PERK, PKR 
and HRI), which are activated in response to distinct indications of cellular 
stress, such as amino acid deficiency, the accumulation of unfolded proteins in 
the ER, viral infection and oxidative damage (Galabru et al., 1989; Harding et 
al., 1999; Lu et al., 2001; Meurs et al., 1990; Sood et al., 2000; Wek et al., 
2006). Thus, the responses to diverse types of cellular stress converge on the 
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induction of ATF4, which in turn activates transcription using C/EBP–ATF 
response elements. ATF4 target genes include genes that function to adapt the 
cells to the stress conditions, genes that are further regulators of the stress 
response, and, in cases of prolonged and irresolvable stress, genes that induce 
cell death (Han et al., 2013; Harding et al., 2003; Wek et al., 2006). 
 
 
2.3.3.3. The composition of C/EBP and ATF transcription  
factors at the TRIB3 promoter during stressful conditions 
It has been demonstrated that ATF4 is able to bind to the TRIB3 C/EBP–ATF 
composite site and thereby activate TRIB3 gene expression in response to 
several types of stress (Ohoka et al., 2005; Örd and Örd, 2005). Additional 
transcription factors that bind to the same DNA element in the TRIB3 gene have 
also been identified, and some of them probably represent heterodimerization 
partners for ATF4, notably C/EBP homologous protein (CHOP), C/EBPβ and 
C/EBPγ. An overview of the transcriptions factors reported to directly regulate 
TRIB3 gene expression is presented in Table 2. 
CHOP, a stress-inducible member of the C/EBP transcription factor family, 
is able cooperate with ATF4 to promote TRIB3 induction in response to cellular 
stress, and possibly binds to the C/EBP–ATF site as a heterodimer with ATF4 
(Ohoka et al., 2005). Additionally, C/EBPβ, C/EBPγ and ATF2 have also been 
shown to bind to the proximal promoter region of TRIB3 (Carraro et al., 2010; 
Huggins et al., 2015; Selim et al., 2007). As with CHOP, ATF4 can also hetero-
dimerize with C/EBPβ and C/EBPγ, and these heterodimers also bind to 
C/EBP–ATF composite sites (Huggins et al., 2015; Lopez et al., 2007; Mann et 
al., 2013; Podust et al., 2001).  
C/EBPβ and C/EBPγ recruitment has been shown to increase mouse Trib3 
expression (Huggins et al., 2015; Li et al., 2008; Morse et al., 2010; Selim et al., 
2007). On the other hand, ATF2 binding to the mouse Trib3 proximal promoter 
region does not appear to be altered by stress, and the deletion of the Atf2 gene does 
not appear to affect the level of Trib3 expression (Carraro et al., 2010). This is in 
line with results obtained studying other genes, where it has been detailed that not 
all transcription factors bound to a functional C/EBP–ATF response element affect 
transcription driven by that element (Averous et al., 2004). Note that at least in 
rodents, the Trib3 proximal promoter region contains an additional possible binding 
site for the C/EBP family members. In mouse and rat, a CHOP–C/EBP composite 
site (consensus sequence: 5′-[G/A][G/A][G/A]TGCAAT[A/C]CCC-3′) has been 
identified in close proximity to the Trib3 C/EBP–ATF site, and mutating either site 
decreases promoter activity in a reporter assay (Cheng et al., 2015; Selim et al., 
2007; Ubeda et al., 1996). 
Thus, the landscape of transcription factor dimers that may be recruited to 
the TRIB3 C/EBP–ATF (and possibly CHOP–C/EBP) site(s) is certainly 
complex; however, when viewed from the endpoint of achieving TRIB3 mRNA 
induction in response to stress, the identified transcriptional regulators are 
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actually quite interdependent. CHOP is known to be a direct ATF4 target gene 
that is strongly induced by ATF4 (Fawcett et al., 1999; Ma et al., 2002). 
Similarly, the expression levels of C/EBPβ and C/EBPγ are also highly ATF4-
dependent (Harding et al., 2003; Huggins et al., 2015). Furthermore, from a 
chromatin structure standpoint, it has been reported that ATF4 functions as a 
‘pioneer factor’ for C/EBP–ATF site-dependent transcription activation, 
facilitating histone acetylation in the target locus to trigger an open chromatin 
state (Shan et al., 2012). Taken together, the induction of ATF4 may be 
considered the critical and initial step in the C/EBP–ATF site-mediated 
upregulation of TRIB3 during stressful conditions. 
 
 
2.3.4. Additional direct regulators of TRIB3 transcription 
In addition to the C/EBP and ATF family members, the transcription factors 
PPARα, FoxO1 and NFATc1 have been reported to directly regulate TRIB3 
transcription (Table 2) (Chan et al., 2011; Koo et al., 2004; Matsumoto et al., 
2006). PPARα, a regulator of hepatic fatty acid metabolism, augments TRIB3 
expression in liver cells, though the promoter element mediating this effect has 
only been localized to a 400-bp region (Koo et al., 2004). FoxO1 binds to the 
murine Trib3 promoter region and has been reported to either activate or repress 
Trib3 expression (in neuronal cells and hepatocytes, respectively), and several 
putative binding sites that correspond to the consensus FoxO response element 
have been proposed (Matsumoto et al., 2006; Zareen et al., 2013). NFATc1 is 
capable of transcriptionally activating TRIB3 in vascular smooth muscle cells 
treated with phenamil (an ion channel inhibitor), and an NFAT consensus 
sequence mediating this effect has been identified at approximately 1 kbp 
upstream of the TRIB3 transcription initiation sites (Chan et al., 2011). 
 
 
2.3.5. Human TRIB3 mRNA isoforms 
The human TRIB3 mRNA population is heterogeneous, consisting of several 
mRNA isoforms that differ in their 5′-UTR (i.e., the first exon) as a result of 
alternative transcription initiation sites and alternative splicing (Örd and Örd, 
2005). Two alternative variants of the first exon have been uncovered, desig-
nated 1A and 1B, which arise from different transcription initiation regions 
(Örd and Örd, 2005). While the 1A variant utilizes a single splice donor site, at 
least four alternative splice donor sites (designated 1B1, 1B2, 1B3 and 1B4) 
have been demonstrated for exon 1B, allowing for a total of at least five 
different mRNA 5′-UTR splice isoforms (Örd and Örd, 2005). Additional 
complexity of the TRIB3 mRNA pool arises from alternative transcription 
initiation sites: more than ten transcription start sites, spanning a region of more 
than 300 bp, have been discovered for splice variant 1A, and close to ten 
mRNA synthesis start sites, which span a region of approximately 50 bp, have 
been identified for splice variant 1B (Örd and Örd, 2005).  
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Table 2. An overview of different modes of TRIB3 gene expression regulation. Only 
regulators that are reported to act directly upon the TRIB3 gene or mRNA are included 
in this table. 
Regulator Result of regulation Reference(s) 
Transcriptional regulation 
ATF4 • Activation of TRIB3 transcription in response to 
several types of cellular stress, including ER 
stress, oxidative stress and nutrient deprivation 
Ohoka et al. (2005); 
Örd and Örd 
(2005); Örd et al. 
(2007) 
C/EBPβ • Activation of TRIB3 transcription in response to 
cellular stress, such as oxidative stress 
Morse et al. (2010); 
Selim et al. (2007) 
C/EBPγ • Activation of TRIB3 transcription in response to 
cellular stress, such as amino acid deprivation 
Huggins et al. 
(2015) 
CHOP 
(DDIT3) 
• Activation of TRIB3 transcription in response to 
several types of cellular stress, such as ER stress 
and oxidative stress 
Morse et al. (2010); 
Ohoka et al. (2005) 
FoxO1 • Activation of TRIB3 transcription in response 
nerve growth factor deprivation in neuronal cells 
• Repression of TRIB3 transcription in hepatocytes
Matsumoto et al. 
(2006); Zareen et 
al. (2013) 
NFATc1 • Activation of TRIB3 transcription in response to 
phenamil, an ion channel inhibitor 
Chan et al. (2011) 
PPARα • Activation of TRIB3 transcription in response to 
PPARα ligand 
Koo et al. (2004) 
Post-transcriptional regulation 
HuR 
(ELAVL1) 
• Elevation of TRIB3 mRNA level in response to 
anoxia 
Rzymski et al. 
(2008) 
miR-24 • Reduction of TRIB3 mRNA level in response to 
platelet-derived growth factor-BB (PDGF-BB) 
Chan et al. (2010) 
miR-96 • Reduction of TRIB3 mRNA level in the absence 
of bone morphogenetic protein 4 (BMP4) 
Kim et al. (2014b) 
 
 
Since all the known exon 1 variants join exon 2 using the same splice acceptor 
site, the TRIB3 open reading frame (ORF) is identical in the different mRNA 
isoforms, and mRNA sequence variation is limited to the (entire)  
5′-UTR (Örd and Örd, 2005). Variation of the 5′-UTR may have a major 
influence on the rate of protein production, as mRNA structural elements 
located in the 5′-UTR control the efficiency of translation initiation, a critical 
point of regulation for eukaryotic translation (Kozak, 2005). Mammalian 
mRNAs may have highly GC-rich 5′-UTRs, which can reduce translation by as 
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much as 100-fold in some cases (Han et al., 2003), and other 5′-UTR sequence 
elements that can have a similar magnitude of effect on translation efficiency 
are known as well (Ghilardi et al., 1998; Kozak, 2001; Kozak, 2005; Lee et al., 
1999). 
 
 
2.3.6. Post-transcriptional regulation of TRIB3 
The TRIB3 transcript has a rapid turnover rate, with mRNA half-life measure-
ment results ranging from slightly less than 20 minutes (Rzymski et al., 2008) 
to approximately 2 or 3 hours (Selim et al., 2007; Sharova et al., 2009; Yacoub 
Wasef et al., 2006). In the comprehensive study by Sharova et al. (2009), where 
the mRNA half-life for nearly 20,000 genes was measured in mouse embryonic 
stem cells, only 9% of genes had a shorter mRNA half-life than Trib3 (half-life 
2.8 hours), and, in the cell type investigated, only a total of 54 genes (0.3%) 
showed mRNA half-lives less than 1 hour, while nearly 1,800 genes (9%) 
showed an mRNA half-life of more than 20 hours. The median mRNA half-life 
for all genes was determined to be 7.1 hours in mouse embryonic stem cells 
(Sharova et al., 2009), which is comparable to that reported for hepatoma cells 
(a median of 10 hours for a sample of approximately 5,200 genes; Yang et al., 
2003). 
Some mechanisms that affect the degradation rate of the TRIB3 transcript 
have been identified (Table 2). Under anoxic conditions, the RNA-binding 
protein HuR has been implicated in stabilizing human TRIB3 mRNA (Rzymski 
et al., 2008), and human TRIB3 mRNA is also a direct target of at least two 
microRNAs, miR-24 and miR-96, through microRNA recognition elements 
located in the mRNA 3′-UTR (Chan et al., 2010; Hsu et al., 2014; Kim et al., 
2014b).  
 
 
2.4. The functions of TRIB3 
While TRIB3 has been found to possess a slight level of catalytic activity under 
specific in vitro conditions, it is not currently known to carry out any biological 
role as a kinase. Rather, TRIB3 is known to function by forming protein–
protein interactions with a variety of different binding partners, including 
several transcription factors (Table 3), protein kinases (Table 4), ubiquitin 
ligases (Table 5) and other proteins (Table 6). In terms of subcellular 
localization, TRIB3 apparently functions in the nucleus and the cytoplasm. The 
interaction of another protein with TRIB3 may result in TRIB3 blocking 
functionally important regions of the interactor, resulting in the inhibition of its 
activity. In other cases, TRIB3 may act as an adaptor or scaffolding protein, 
targeting one protein to the proximity of another. Using these modes of action, 
TRIB3 participates in a range of intracellular signaling processes, typically 
acting as a negative regulator. 
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2.4.1. TRIB3 regulates the cellular stress response and cell death 
As described in section 2.3.2, a major distinctive feature of TRIB3 gene expres-
sion is its induction in response to cellular stress. In keeping with this, TRIB3 
has been found to physically interact with and regulate several factors central to 
the cellular stress response and cell death. Intriguingly, depending on the 
cellular context and stress type, TRIB3 possesses substantial pro- as well as 
anti-survival roles in stressed cells. At the same time, genome-wide loss-of-
function screens utilizing CRISPR/Cas9 or gene trap methods in haploid human 
cell lines, which enables the direct generation of pools of knockout cells, have 
revealed that TRIB3 is non-essential for cell proliferation and survival under 
standard culture conditions (TRIB1 and TRIB2 likewise; Blomen et al., 2015; 
Wang et al., 2015). This is compatible with a stress- or other stimulus 
condition-dependent and/or cell type-specific role for TRIB3. 
 
 
2.4.1.1. TRIB3 is a negative feedback inhibitor of ATF4,  
a master regulator of stress response transcription 
One of the known functions of TRIB3 in the context of cellular stress is the 
inhibition ATF4 (Bowers et al., 2003; Örd and Örd, 2003), a bZIP transcription 
factor that is, as mentioned previously (2.3.3.2), the central transcriptional 
activator of the integrated stress response to diverse types of cellular stress. 
Since TRIB3 is among the genes activated by ATF4 in response to stress 
(2.3.3.3), the inhibition of ATF4 by TRIB3 provides a negative feedback 
mechanism for the regulation of ATF4 activity (Ohoka et al., 2005; Örd and 
Örd, 2005).  
Early on, Drosophila Tribbles was found to negatively regulate target proteins, 
including the bZIP transcription factor Slbo, by promoting their proteasome-
mediated destruction (Grosshans and Wieschaus, 2000; Mata et al., 2000; Rorth et 
al., 2000; Seher and Leptin, 2000). However, TRIB3 is able to inhibit ATF4 
without increasing the rate of ATF4 degradation (Örd and Örd, 2003). Rather, 
TRIB3 appears to function by directly repressing the transcriptional activity of 
ATF4 (Ohoka et al., 2005; Örd and Örd, 2003; Örd and Örd, 2005).  
TRIB3 binds to the transactivation domain of ATF4 and blocks the associ-
ation between ATF4 and its transcriptional co-activators, such as the histone 
acetyltransferase p300 (Ohoka et al., 2007; Örd and Örd, 2003). When in 
complex with TRIB3, ATF4 is still able to bind its target DNA sequence, thus it 
is possible that the interaction between ATF4 and TRIB3 takes place while 
ATF4 is bound to its target genes (Örd and Örd, 2003).  
The modulation of ATF4 activity by TRIB3 has been found to be important 
for the fine-tuning of ATF4-dependent transcription in stressed cells, and, 
during severe stress where the ATF4-driven transcriptional program promotes 
cell death, endogenous TRIB3 is able to prolong cell survival by restricting 
endogenous ATF4 activity (Jousse et al., 2007; Örd et al., 2007). 
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Table 3. Transcription factors reported to physically interact with TRIB3. Only 
interactions with known functional significance are included in this table. 
Protein Result of 
interaction 
Biological significance Reference(s) 
ATF4 Inhibition of ATF4 
transcriptional 
activity 
• Negative feedback regulation 
of ATF4 activity 
• Regulation of the cellular 
stress response 
• Suppression of cell death 
Bowers et al. 
(2003); Jousse et 
al. (2007); Ohoka 
et al. (2005); Örd 
and Örd (2003); 
Örd and Örd 
(2005); Örd et al. 
(2007) 
C/EBPβ Inhibition of 
C/EBPβ 
transcriptional 
activity 
• Inhibition of adipocyte 
differentiation 
• Potential for negative 
feedback regulation of 
C/EBPβ activity 
Bezy et al. 
(2007); Selim et 
al. (2007) 
CHOP 
(DDIT3) 
Inhibition of CHOP 
transcriptional 
activity 
• Negative feedback regulation 
of CHOP activity 
Ohoka et al. 
(2005); Ohoka et 
al. (2007) 
PPARγ Inhibition of PPARγ 
transcriptional 
activity 
• Inhibition of adipocyte 
differentiation 
Takahashi et al. 
(2008) 
RelA 
(p65) 
Inhibition of NF-κB 
transcriptional 
activity 
• Negative feedback regulation 
of NF-κB activity 
• Inhibition of pro-
inflammatory responses 
• Promotion of cell death 
Duggan et al. 
(2010); Smith et 
al. (2011); Wu et 
al. (2003) 
SMAD3 Potentiation of 
SMAD3 
transcriptional 
activity; 
maintenance of 
SMAD3 nuclear 
localization 
• Positive feedback regulation 
of TGF-β‒SMAD3 activity 
• Promotion of tumor cell 
migration and invasion 
Hua et al. (2011) 
 
 
2.4.1.2. TRIB3 inhibits CHOP and C/EBPβ,  
bZIP transcription factors situated downstream of ATF4 
CHOP and C/EBPβ are C/EBP family transcription factors that form heterodi-
mers with ATF4 for the regulation of C/EBP–ATF composite site-dependent 
transcription (Fawcett et al., 1999; Lopez et al., 2007; Mann et al., 2013; Ohoka 
et al., 2005; Podust et al., 2001), and both CHOP and C/EBPβ have a relation-
ship with TRIB3 that is reminiscent of the relationship between ATF4 and 
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TRIB3. That is, TRIB3 is able to physically interact with and inhibit the tran-
scriptional activity of CHOP as well as C/EBPβ, and, since both of these tran-
scription factors can also activate the TRIB3 promoter, there exists the potential 
for TRIB3 to provide negative feedback regulation of CHOP and C/EBPβ 
activity in conditions of cellular stress (Bezy et al., 2007; Carraro et al., 2010; 
Li et al., 2008; Ohoka et al., 2005; Ohoka et al., 2007; Selim et al., 2007).  
Given that both CHOP and C/EBPβ are inducible by ATF4 during stress 
(Fawcett et al., 1999; Harding et al., 2003; Ma et al., 2002), TRIB3 has the 
capability to provide negative feedback of multiple successive steps of the 
stress-associated transcriptional program. In the transcriptional network 
controlling the cellular stress response, CHOP is regarded as a decidedly pro-
apoptotic transcription factor, especially in the context of ER stress, and 
multiple apoptosis-promoting mechanisms that act downstream of CHOP have 
been identified (Li et al., 2014). Likewise, C/EBPβ can also assert a negative 
effect on cell viability by facilitating apoptosis in response to challenging 
conditions (Meir et al., 2010; Mukherjee et al., 2001; Sun et al., 2005; Zinszner 
et al., 1998). Therefore, the inhibition of CHOP- and C/EBPβ-dependent pro-
apoptotic transcription by TRIB3 represents a potential mechanism for 
augmenting cell survival. 
Consequently, it is intriguing that there are exist combinations of stress and 
cell type in which the ATF4–CHOP pathway induces TRIB3 expression, and 
cell death is triggered in a CHOP-dependent manner, yet the ultimate effect of 
TRIB3 on cell survival is pro-death, rather than a pro-survival effect as would 
be expected for a feedback inhibitor of the pro-apoptotic CHOP (Ohoka et al., 
2005; Shang et al., 2009; Shang et al., 2010). Apparently, TRIB3 can alterna-
tively act as a downstream ‘death executor’ for CHOP; a potential mechanism 
for this is described in the next section. 
 
 
2.4.1.3. Inhibition of Akt by TRIB3 in the context of cellular stress 
In the liver, TRIB3 was discovered to be an inhibitor of the protein kinase Akt, 
specifically its isoforms Akt1 and Akt2, in the context of insulin signaling (Du 
et al., 2003), though this function of TRIB3 has been called into question, at 
least under a normal metabolic state (Iynedjian, 2005; Okamoto et al., 2007). 
However, in cells suffering from stress, Akt can exert a pro-survival effect, and 
the inhibition of Akt activity is a way by which stress-induced TRIB3 can 
provoke cell death (Borsting et al., 2014; Cheng et al., 2015; Humphrey et al., 
2010; Humphrey et al., 2014; Salazar et al., 2013; Zareen et al., 2013). 
Mechanistically, TRIB3 was found to directly bind to Akt1/2 and reduce the 
phosphorylation of Akt at serine 473 and threonine 308, two modifications that 
indicate Akt activation, and to reduce the phosphorylation of Akt target proteins 
(Du et al., 2003). The total amount of Akt protein does not appear to be affected 
by TRIB3 (Du et al., 2003). The phosphorylation of Akt at serine 473 is carried 
out by the mechanistic target of rapamycin complex 2 (mTORC2), and recently 
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TRIB3 was shown to interact with the kinase mTOR as well as with RICTOR, 
the mTORC2-specific companion of mTOR (Borsting et al., 2014). Based on 
this, it has been suggested that the binding of mTORC2 by TRIB3 may also be 
involved in the mechanism of TRIB3-mediated Akt inhibition (Borsting et al., 
2014). The inhibitory effect of TRIB3 on Akt activation is enhanced by the 
MAPK kinase kinase MLK3, which forms a complex with TRIB3 and stabilizes 
the TRIB3 protein, leading to increased Akt inhibition and reduced cell survival 
(Humphrey et al., 2010). 
 
 
Table 4. Protein kinases reported to physically interact with TRIB3. Only 
interactions with known functional significance are included in this table. 
Protein Result of 
interaction 
Biological significance Reference(s) 
Akt1/2 Inhibition of Akt 
activation 
• Reduction of Akt kinase 
activity 
• Suppression of 
tumorigenesis 
• Promotion of apoptosis 
• Reported to affect as well 
as not affect insulin 
signaling, glucose 
metabolism and insulin 
resistance 
Du et al. (2003); 
Humphrey et al. 
(2010); Iynedjian 
(2005); Koh et al. 
(2013); Okamoto et 
al. (2007); Prudente 
et al. (2005); 
Salazar et al. 
(2015); Zou et al. 
(2009) 
BMPR2 BMP4-sensitive 
inhibition of 
SMURF1 
degradation 
• Positive regulation of 
BMP and TGF-β signaling
• Facilitation of osteoblastic 
differentiation 
• Maintenance of smooth 
muscle cell phenotype 
Chan et al. (2007) 
MEK1 
(MAP2K1) 
Putative regulation 
of MAPKK activity
• Activation or inhibition of 
MAPK pathways, 
depending on TRIB3 dose
Kiss-Toth et al. 
(2004) 
MKK7 
(MAP2K7) 
Putative regulation 
of MAPKK activity
• Activation or inhibition of 
MAPK pathways, 
depending on TRIB3 dose
Kiss-Toth et al. 
(2004) 
MLK3 
(MAP3K11) 
Stabilization of 
TRIB3 and MLK3 
proteins 
• Enhanced Akt inhibition 
by TRIB3 
• Promotion of apoptosis 
Humphrey et al. 
(2010); Humphrey 
et al. (2014) 
mTOR Inhibition of 
mTORC2 activity 
• Reduced Akt S473 
phosphorylation 
• Resistance to diabetic 
kidney disease 
Borsting et al. 
(2014) 
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2.4.1.4. TRIB3 can directly affect NF-κB  
activity in cells subjected to stress 
TRIB3 can also contribute to cell death by regulating NF-κB, a central 
transcription factor for the promotion of inflammatory responses, cell survival 
and cell proliferation (Fang et al., 2014; Rzymski et al., 2008; Wu et al., 2003).  
TRIB3 physically interacts with the NF-κB member RelA, a transcription 
activator, and can inhibit NF-κB activity (Duggan et al., 2010; Rzymski et al., 
2008; Smith et al., 2011; Wu et al., 2003). TRIB3 reduces RelA phos-
phorylation by protein kinase A, a mechanism for the activation of NF-κB, but 
does not repress the nuclear translocation of RelA or RelA binding to DNA (Wu 
et al., 2003). As NF-κB can contribute to the upregulation of TRIB3 expression 
in response to cellular stress and cytokines, TRIB3 functions as a negative 
feedback regulator of NF-κB activity (Rzymski et al., 2008; Wu et al., 2003). 
Additionally, TRIB3 can inhibit NF-κB as a downstream effector of the ATF4–
CHOP pathway (Rzymski et al., 2008; Smith et al., 2011).  
TRIB3 has been found to accelerate cell death by repressing NF-κB 
(Rzymski et al., 2008; Wu et al., 2003); however, recently there have also been 
reports that TRIB3 can increase NF-κB activity (Fang et al., 2014; Yu et al., 
2015). Nevertheless, the effect of TRIB3 on cell survival was found to be 
negative in such a case as well, since, unusually, NF-κB activity aggravates cell 
death induced by ER stress in pancreatic β-cells (Fang et al., 2014). 
 
 
2.4.1.5. TRIB3: a caspase-3 substrate and regulator 
Caspases are a family of aspartate-directed cysteine proteases that are 
responsible for carrying out apoptotic cell death, and they function in a 
hierarchical manner, in which ‘apical’ (initiator) caspases cleave the inactive 
pro-forms of ‘executioner’ (effector) caspases, thereby activating the latter, 
which then proceed to cleave other cellular proteins and irreversibly commit the 
cell to apoptosis (Inoue et al., 2009).  
Human TRIB3 is a substrate for at least seven caspases, including multiple 
initiator and effector caspases, and is implicated in the regulation of cell death 
by modulating caspase activity (Shimizu et al., 2012). Caspases 3, 6, 7, 8, 9 and 
10 proteolytically cleave TRIB3 at a site located twenty amino acid residues 
from the C-terminus, while caspase-2 cleaves more close to the C-terminus 
(Shimizu et al., 2012).  
In cells subjected to apoptosis-inducing treatment, the cleavage of TRIB3 
expedites apoptosis and augments the activation of executioner caspases 3 and/or 7 
(Shimizu et al., 2012). However, under certain stress conditions, for instance 
tunicamycin-induced ER stress in HeLa cells, TRIB3 was found to be uncleaved, 
even though caspase-3/7 activation was detected and the mode of cell death was 
predominantly apoptotic (Shimizu et al., 2012). In this case, TRIB3 (herein 
uncleaved) suppressed caspase-3/7 activation and asserted an anti-apoptotic effect 
on cell viability, possibly since TRIB3 promoted the nuclear translocation of 
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procaspase-3, which appeared to preclude caspase-3 activation (Shimizu et al., 
2012). Thus, TRIB3 can serve either a pro- or anti-apoptotic role by regulating 
caspase activation, and the additional factors that determine the direction of the 
effect of TRIB3 in this context are currently unknown. 
 
 
2.4.2. TRIB3 is involved in protein degradation 
The prototypical member of the Tribbles protein family, Drosophila Tribbles, 
was originally found to exert its effects by targeting specific proteins for ubiq-
uitination, leading to their destruction by the proteasome (Grosshans and 
Wieschaus, 2000; Mata et al., 2000; Rorth et al., 2000; Seher and Leptin, 2000), 
and this mode of function is also used by mammalian TRIB3 in a variety of 
different contexts. Accompanying this, TRIB3 is itself subject to ubiquitination-
mediated degradation. In addition to the ubiquitin–proteasome system, TRIB3 is 
also associated with regulating autophagy, the other main route of intracellular 
protein degradation. 
 
 
2.4.2.1. TRIB3 is linked to TGF-β and BMP signaling  
by E3 ubiquitin ligases SMURF1 and SMURF2 
The proteins SMURF1 (‘SMAD-specific E3 ubiquitin protein ligase 1’) and 
SMURF2 are E3 ubiquitin ligases that participate in receptor-mediated signaling by 
regulating the degradation of SMAD proteins, the intracellular signal transducers 
for transforming growth factor β (TGF-β) and bone morphogenetic protein (BMP) 
signaling, though many other targets have also been identified for SMURF1/2 
(David et al., 2013; Zhu et al., 1999). TRIB3 interacts with both SMURF1 and 
SMURF2, and, in both cases, TRIB3 induces the degradation of the SMURF 
protein by the ubiquitin–proteasome pathway (Chan et al., 2007; Hua et al., 2011). 
Since SMURF2 promotes the proteasomal degradation of SMAD2 and 
SMAD3, two downstream transducers of TGF-β signaling, TRIB3 is able to 
augment TGF-β–SMAD signaling by decreasing the abundance of SMURF2 
(Hua et al., 2011). In addition to reducing the degradation rate of SMAD2/3, 
TRIB3 further enhances SMAD3 transcriptional activity by interacting with 
SMAD3 and promoting its nuclear localization (Hua et al., 2011). Moreover, a 
positive feedback loop may exist between TRIB3 and TGF-β–SMAD3 
signaling, since TRIB3 expression is upregulated in response to stimulation with  
TGF-β or the overexpression of SMAD3 (Hua et al., 2011). 
SMURF1 degradation is triggered by TRIB3 in response to simulation with 
BMP (Chan et al., 2007). TRIB3 binds to the cytoplasmic region of the BMP type 
II receptor (BMPR2) in unstimulated cells, but dissociates upon BMP4 binding and 
proceeds to induce proteasomal degradation of SMURF1 (Chan et al., 2007). By 
promoting the destruction of SMURF1, TRIB3 has been shown to decrease 
SMURF1-mediated degradation of SMAD1, SMAD7 and RhoA, thereby positively 
modulating BMP, TGF-β and Rho kinase signaling, respectively (Chan et al., 2007).  
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2.4.2.2. TRIB3 interacts with several other E3 ubiquitin ligases as well 
As mentioned earlier, one of the originally discovered functions of Drosophila 
Tribbles is triggering the ubiquitination-mediated degradation of the cell cycle-
regulating phosphatase String, a homolog of mammalian CDC25 proteins 
(Grosshans and Wieschaus, 2000; Mata et al., 2000; Seher and Leptin, 2000). 
Possibly related to this in an evolutionary sense, TRIB3 has been reported to 
bind to CDC25A and positively or negatively regulate its stability, although the 
significance of this TRIB3 interaction for the regulation of cell cycle progres-
sion by CDC25A is unknown (Sakai et al., 2010). The results of Sakai et al. 
(2010) demonstrate that TRIB3 increases CDC25A ubiquitination and degrada-
tion under normal growth conditions but stabilizes CDC25A in response to 
DNA damage. Two ubiquitin ligase complexes, SCFβ-TrCP and APC/CCDH1, 
previously known to induce CDC25A breakdown, are implicated in mediating 
the destabilizing effect of TRIB3 on CDC25A (Sakai et al., 2010).  
Interestingly, the APC/CCDH1 ubiquitin ligase complex is also involved in the 
ubiquitination and turnover of TRIB3 via an interaction between TRIB3 and 
CDH1, the co-activator protein of APC/C, indicating a possible regulatory net-
work involving TRIB3, CDC25A and APC/CCDH1 (Ohoka et al., 2010; Sakai et 
al., 2010). Another E3 ubiquitin ligase, SIAH1, has also been found to interact 
with and ubiquitinate TRIB3, thereby accelerating the turnover of TRIB3 
protein (Zhou et al., 2008b). 
All three Tribbles homologs present in mammals are able to physically 
interact with the E3 ubiquitin ligase COP1, although the proteins targeted for 
degradation via COP1 binding differ somewhat between the different 
mammalian Tribbles proteins (Dedhia et al., 2010; Keeshan et al., 2010; Qi et 
al., 2006; Yokoyama et al., 2010; Yoshida et al., 2013). Whereas TRIB1 and 
TRIB2 are efficient at triggering the degradation of C/EBPα, a transcription 
factor that promotes myeloid differentiation, such an ability is absent in the case 
of TRIB3 (Dedhia et al., 2010). Due to this functional difference, unrestrained 
expression of TRIB1 or TRIB2 induces leukemia, while the misexpression of 
TRIB3 does not (Dedhia et al., 2010; Keeshan et al., 2006; Yokoyama et al., 
2010; Yoshida et al., 2013). TRIB1, 2 and 3 all appear to be able to direct 
COP1 to target acetyl-CoA carboxylase (ACC), the rate-limiting enzyme in 
fatty acid synthesis, for proteasomal destruction (Dedhia et al., 2010). However, 
this function has most thoroughly been validated in the case of overexpressed 
TRIB3 (Qi et al., 2006). 
Recent results reveal that TRIB3 binds to a further E3 ubiquitin ligase, 
Parkin, which is a protein that protects against Parkinson’s disease by 
facilitating the clearance of pathogenic substrates (Aime et al., 2015). TRIB3 
expression leads to decreased Parkin protein level, without affecting the mRNA 
level, and enhances cell death in cellular models of Parkinson’s disease (Aime 
et al., 2015). 
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Table 5. Ubiquitin ligases reported to physically interact with TRIB3. Only inter-
actions with known functional significance are included in this table. 
Protein Result of 
interaction 
Biological significance Reference 
APC/CCDH1 
(FZR1) 
Ubiquitination of 
TRIB3 by APC/C 
• Decreased half-life of TRIB3 
protein due to proteasomal 
degradation 
Ohoka et al. 
(2010) 
COP1 
(RFWD2) 
Ubiquitination of 
ACC1 by COP1, 
proteasomal 
degradation of 
ACC1 
• Decreased fatty acid synthesis 
• Resistance to diet-induced 
obesity 
Qi et al. (2006) 
Parkin 
(PARK2) 
Decreased Parkin 
protein level 
• Promotion of cell death in 
cellular models of Parkinson’s 
disease 
Aime et al. 
(2015) 
SIAH1 Ubiquitination of 
TRIB3 by SIAH1 
• Decreased half-life of TRIB3 
protein due to proteasomal 
degradation 
Zhou et al. 
(2008b) 
SMURF1 Ubiquitination and 
proteasomal 
degradation of 
SMURF1 
• Decreased SMURF1-mediated 
degradation of SMAD1, 
SMAD7 and RhoA 
• Activation of BMP and TGF-β 
signaling 
Chan et al. 
(2007) 
SMURF2 Ubiquitination and 
proteasomal 
degradation of 
SMURF2 
• Decreased SMAD3 
ubiquitination by SMURF2 
• Activation of TGF-β–SMAD 
signaling 
• Promotion of tumor cell 
migration and invasion 
Hua et al. 
(2011) 
 
 
2.4.2.3. TRIB3 in autophagy: a dichotomy 
In addition to interacting with ubiquitin ligases, TRIB3 is implicated in regu-
lating protein degradation on a more general level by negatively affecting the 
clearance of autophagic and proteasomal substrates (Hua et al., 2015b). 
Sequestosome 1 (SQSTM1), frequently known as p62, is a selective autophagy 
receptor that binds to ubiquitinated proteins and targets them to autophago-
somes for subsequent degradation (Rogov et al., 2014). TRIB3 binds to 
SQSTM1 and blocks its function, resulting in the attenuation of autophagic flux 
and the accumulation of SQSTM1 (Hua et al., 2015b). The accumulation of 
SQSTM1 underlies the inhibition of the ubiquitin–proteasome system by 
TRIB3, possibly due to competition between proteasomal delivery receptors 
and SQSTM1 for the binding of ubiquitinated substrates, which leads to 
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Table 6. TRIB3-interacting proteins of various functional categories, except 
transcription factors (presented separately in Table 3), protein kinases (Table 4) 
and ubiquitin ligases (Table 5). Only interactions with known biological significance 
are included in this table. 
Protein Result of interaction Biological significance Reference(s) 
ACC1/2 
(ACACA, 
ACACB) 
Ubiquitination of 
ACC by COP1, 
proteasomal 
degradation of ACC 
• Decreased fatty acid 
synthesis 
• Resistance to diet-induced 
obesity 
Qi et al. 
(2006) 
APOBEC3A Possible reduction of 
APOBEC3A 
abundance 
• Possible decrease in nuclear 
DNA editing and increase in 
genome integrity 
Aynaud et al. 
(2012); Land 
et al. (2013) 
Caspase-3 Cleavage of TRIB3 at 
position D338 
• Suppression of apoptosis by 
uncleaved TRIB3 via pre-
vention of caspase-3 activation
Shimizu et al. 
(2012) 
CDC25A Regulation of 
ubiquitination-
mediated CDC25A 
degradation 
• Differential CDC25A 
stability in normal and 
genotoxic conditions 
Sakai et al. 
(2010) 
CtIP 
(RBBP8) 
Unknown/binding of 
TRIB3 and CtIP 
• UV-sensitive dot-like nuclear 
co-localization of TRIB3 and 
CtIP 
Xu et al. 
(2007) 
IRS1 Inhibition of IRS1 
phosphorylation at 
Y612 
• Inhibition of proximal insulin 
signaling 
Koh et al. 
(2013) 
PCAF 
(KAT2B) 
Unknown (possibly 
the acetylation of 
TRIB3) 
• TRIB3 hypo-acetylation  
may contribute to its Akt-
inhibiting activity 
Yao and 
Nyomba 
(2008) 
RICTOR Inhibition of 
mTORC2 activity 
• Reduced Akt S473 
phosphorylation 
• Resistance to diabetic kidney 
disease 
Borsting et al. 
(2014) 
SMYD1 Methylation of 
TRIB3 
• Enhanced SMYD1-mediated 
repression of transcription by 
methylated TRIB3 
• Potential positive feedback 
regulation of SMYD1 activity 
Rasmussen et 
al. (2015) 
SQSTM1 
(p62) 
Inhibition of 
SQSTM1 binding to 
LC3; accumulation of 
SQSTM1 
• Attenuation of autophagic 
and proteasomal degradation 
• Promotion of tumor cell 
proliferation and invasion 
• Promotion of tumor growth, 
metastasis and recurrence 
Hua et al. 
(2015b) 
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ubiquitinated proteins being denied access to the proteasome (Hua et al., 2015a; 
Hua et al., 2015b). Consequently, the two main pathways for the degradation of 
intracellular proteins, the autophagy–lysosome route and the ubiquitin–proteasome 
system, can both be inhibited by TRIB3, and, through this, TRIB3 has been linked 
to accelerated tumor progression in mouse models (Hua et al., 2015b).  
On the other hand, TRIB3 has also been reported to stimulate autophagy by 
inhibiting Akt, thereby leading to mTORC1 inactivation, a common molecular 
event for triggering autophagy (Salazar et al., 2009b; Salazar et al., 2013; Vara 
et al., 2011). This mode of TRIB3 action is necessary for cannabinoid-induced 
autophagy in glioma and hepatoma cells, and represents a potential mechanism 
of anti-cancer therapy (Salazar et al., 2009b; Vara et al., 2011). Thus, in 
different situations, TRIB3 may apparently have opposing effects on autophagy. 
 
 
2.4.3. TRIB3 in development and differentiation 
2.4.3.1. Trib3-deficient mice appear normal under standard conditions 
Knockout mice provide valuable information about the functions of a gene at 
endogenous levels of expression. As such, mice with a targeted disruption of the 
Trib3 gene have been generated and studied by several groups (Table 7). 
Additionally, several transgenic mouse lines with tissue-specific overexpression 
of Trib3 have also been created and characterized (Table 8). 
Homozygous Trib3 knockout (Trib3−/−) mice are viable and physically grossly 
normal, and the crossing of Trib3 heterozygotic (Trib3+/−) individuals leads to all 
genotypes being born in the expected Mendelian ratio (Okamoto et al., 2007). These 
results resemble what has been observed in mice with a deletion of Trib1 or Trib2 
(Takasato et al., 2008; Yamamoto et al., 2007). The International Mouse Phenotyping 
Consortium has recently released phenotyping data from the analysis of adult Trib3 
knockout mice, including the characterization of morphology, basic physiology, 
clinical chemistry, hematology and basic behavioral responses, and currently no 
significant phenotype associations have been found, although the statistical power 
may be limited in some cases (data available at: www.mousephenotype.org, accessed 
2015-10-29, database release 3.4; Koscielny et al., 2014).  
It has been postulated that in the single-knockout mouse lines, other Tribbles 
homologs might functionally compensate for the lack of one Tribbles family 
member (Takasato et al., 2008). However, the typical expression patterns of the 
different Tribbles family members overlap only partially (as discussed in 
section 2.3.1), and, in Trib3−/− mice, unaltered expression of Trib1 and Trib2 
was observed in the liver, white adipose tissue, brown adipose tissue and 
skeletal muscle (Okamoto et al., 2007). Moreover, functional redundancy would 
seem more probable between Trib1 and Trib2 than between either of them and 
Trib3, since the amino acid sequences of TRIB1 and TRIB2 are considerably 
more similar to each other than to TRIB3 (as described in section 2.2.3). 
Nevertheless, the creation of double- or triple-knockout mouse lines could yield 
new insights into the functions of the Tribbles homologs in mammals. 
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Table 7. Characteristics of Trib3-deficient mice. 
Phenotype of Trib3 knockout mice Reference 
• Viable, physically grossly normal, born in the expected 
Mendelian ratio 
• Unmodified insulin and glucose tolerance 
• Normal hepatic insulin signaling, serum biochemistry, body 
composition and metabolic rate 
Okamoto et al. 
(2007) 
• Normal splenic macrophages and lymphocytes Satoh et al. (2013) 
• On a standard rodent chow diet: unaltered body weight, 
blood glucose level and glucose tolerance 
• On a high-fat diet: improved glucose tolerance, less body 
weight gain, lower fasting levels of serum glucose and 
insulin, decreased liver weight and triglyceride content, 
unaltered fat pad weight 
Koh et al. (2013) 
• Unaltered developmental apoptosis of superior cervical 
ganglion neurons 
Zareen et al. (2013) 
• Normal baseline kidney function and structure 
• With streptozotocin-induced diabetes: increased severity of 
diabetic kidney disease 
Borsting et al. (2014) 
• No effect on pancreatic β-cell mass and size 
• Normal glucose tolerance, growth and body weight 
Humphrey et al. 
(2014) 
• Low, unaltered baseline incidence of tissue lesions in several 
organs at 8 months of age 
• In a chemical carcinogenesis model of skin cancer: 
accelerated malignant progression  
• In a genetic model of cancer predisposition: increased incidence 
of premalignant and malignant lesions in several organs 
Salazar et al. (2015) 
• No evident alterations in the anatomy or cellular content of 
the cortical and subcortical regions of the brain 
Aime et al. (2015) 
• Enhanced insulin signaling in brown adipose tissue Jeong et al. (2016) 
• International Mouse Phenotyping Consortium: 
no statistically significant phenotype associations found for 
adult mice in analyses that span morphology, basic 
physiology, clinical chemistry, hematology and basic 
behavioral experiments (data available at: 
www.mousephenotype.org, accessed 2015-10-29) 
International Mouse 
Phenotyping 
Consortium (database 
release 3.4; Koscielny 
et al., 2014) 
 
 
Since previous work by Du et al. (2003) had implicated TRIB3 in insulin 
signaling in the liver, an organ with a principal role in glucose homeostasis, 
Okamoto et al. (2007) carried out a thorough characterization of the glucose and 
energy metabolism of adult Trib3−/− mice maintained under standard conditions 
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(e.g., feeding with a standard rodent chow diet ad libitum). The results revealed 
that Trib3-deficient mice have normal serum metabolic parameters and body 
composition, as well as unaltered hepatic insulin signaling and glucose metabo-
lism (Okamoto et al., 2007). Additionally, no discernible effect in insulin or 
glucose tolerance was found compared to wild type controls, and whole-body 
metabolic rate and energy expenditure were also not affected by the deletion of 
Trib3 (Okamoto et al., 2007). Adequate production of insulin by pancreatic  
β-cells is also critical for the control of glucose homeostasis, and an analysis of 
Trib3 knockout mice has revealed that they have no apparent differences in 
pancreatic β-cell mass and size (Humphrey et al., 2014). Thus, the global loss of 
Trib3 does not appear to affect the maintenance of glucose homeostasis in mice 
maintained under standard conditions. 
Further studies performed with Trib3 knockout mice have revealed that 
Trib3−/− individuals also have normal baseline kidney function and structure 
(Borsting et al., 2014) and normal macrophage and lymphocyte populations in 
the spleen (Satoh et al., 2013).  
Consistent with the results obtained from Trib3 knockouts, the analysis of 
transgenic mice that conditionally overexpress human TRIB3 in a Cre recom-
binase-dependent manner revealed that ten days of enforced TRIB3 expression 
in the liver, spleen and kidney causes no apparent histological differences in 
kidney and spleen (Sakai et al., 2014). However, in the mouse liver, the Cre-
mediated overexpression of human TRIB3 gave rise to an increase in hepatocyte 
nuclear size as well as slight inflammation in the perivascular regions, com-
pared to Cre-treated wild type mice (Sakai et al., 2014).  
 
 
2.4.3.2. Transgenic models implicate TRIB3 in myocyte physiology 
Transgenic mice that overexpress Trib3 in a skeletal muscle-specific manner 
display a dramatically increased endurance exercise capacity and a pronounced 
increase in the proportion of oxidative muscle fibers (An et al., 2014). No 
difference in their overall body weight is evident, though the weights of indi-
vidual muscles tend to be elevated compared to wild type controls (An et al., 
2014). Metabolically, Trib3 overexpression in skeletal muscle has no effect on 
muscle or whole-body glucose homeostasis; however, in vitro analysis of the 
transgenic muscle revealed decreased basal but unaltered contraction-stimulated 
fatty acid oxidation (An et al., 2014). 
Transgenic mice that overexpress Trib3 specifically in cardiac muscle have 
also been generated, and these mice develop hearts with normal size and con-
tractile function (Avery et al., 2010). However, metabolically, Trib3 
overexpression in the heart leads to a reduced glucose oxidation rate without 
affecting the rate of fatty acid oxidation (Avery et al., 2010). Comparably to 
Trib3-overexpressing skeletal muscle, Trib3-overexpressing hearts display 
elevated expression of slow-twitch myosin, which is associated with oxidative 
skeletal muscle fibers (An et al., 2014; Avery et al., 2010). Recently, it has been 
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demonstrated that TRIB3 interacts with and functions as a transcription co-
repressor for SMYD1, a factor required for embryonic heart development 
(Rasmussen et al., 2015), though whether this is associated with the phenotype 
of the mice that overexpress Trib3 in cardiac muscle remains unknown. Overall, 
these results indicate that TRIB3 is able to influence muscle composition in 
skeletal as well as cardiac muscle. 
 
 
Table 8. Characteristics of transgenic mice that overexpress TRIB3. 
Genetic modification Phenotype of mutant mice Reference 
Adipose tissue-
specific 
overexpression of 
Trib3 
• Less white adipose tissue, slower 
weight gain 
• Increased dietary intake 
• Blood glucose level decreased, fatty 
acid level increased 
• Protection from diet-induced obesity 
Qi et al. (2006) 
Cardiac  
muscle-specific 
overexpression of 
Trib3 
• Normal baseline heart size and 
contractile function 
• Increased heart damage after 
myocardial infarction 
Avery et al. (2010) 
Pancreatic  
β-cell-specific 
overexpression of 
Trib3 
• At 4 months of age: unaltered body 
weight and insulin sensitivity  
• At older ages: decreased glucose 
tolerance, insulin secretion, pancreatic 
β-cell mass and proliferation 
Liew et al. (2010) 
Skeletal  
muscle-specific 
overexpression of 
Trib3 
• Greatly increased endurance exercise 
capacity 
• Increased proportion of oxidative 
muscle fibers 
• Normal muscle and whole-body 
glucose homeostasis 
An et al. (2014) 
Conditional 
overexpression of 
human TRIB3 
• Ten days after adenoviral delivery of 
Cre recombinase: increased hepatocyte 
nuclear size, slight perivascular 
inflammation in the liver, unaltered 
kidney and spleen histology (compared
to Cre-treated wild type) 
Sakai et al. (2014) 
 
 
In vitro models also implicate TRIB3 in the regulation of vascular smooth muscle 
cell phenotype due to its ability to trigger BMP-induced degradation of SMURF1 
(Chan et al., 2007). In response to BMP stimulation of vascular smooth muscle 
cells, microRNA miR-96 is repressed, leading to the derepression of Trib3 and 
thereby to the promotion of a contractile phenotype (Kim et al., 2014b). In 
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contrast, platelet-derived growth factor (PDGF)-BB stimulation of vascular 
smooth muscle cells downregulates Trib3 via the induction of miR-24, leading to 
the promotion of a proliferative phenotype (Chan et al., 2010). Thus, Trib3 is 
linked to myocyte function in skeletal, smooth and cardiac types of muscle. 
 
2.4.3.3. A potential role for TRIB3 in adipose tissue 
On a standard chow diet, mice with an adipose tissue-specific overexpression of 
Trib3 gain weight more slowly than their wild type littermates and display a 
reduced amount of white adipose tissue relative to body weight, even though 
they actually consume more calories (Qi et al., 2006). Accompanying this, 
adipocyte size is decreased in the Trib3-overexpressing adipose tissue, and the 
transgenic mice additionally exhibit lower glucose but higher fatty acid 
concentrations in blood on a standard chow diet (Qi et al., 2006). Trib3-
overexpressing adipocytes were found to display an increased fatty acid oxida-
tion rate and reduced activity of ACC, the rate-limiting enzyme in fatty acid 
synthesis (Qi et al., 2006). Mechanistically, TRIB3-induced ubiquitination of 
ACC by the ubiquitin ligase COP1 (discussed in section 2.4.2.2) is thought to 
underlie the phenotype of the mice with adipose tissue-specific overexpression 
of Trib3 (Qi et al., 2006).  
In addition to the inhibitory effect of Trib3 overexpression on fat accumula-
tion into adipocytes, TRIB3 is also implicated in the suppression of multiple 
stages of adipocyte differentiation, based on in vitro models of adipogenesis 
(Bezy et al., 2007; Jeong et al., 2016; Naiki et al., 2007; Takahashi et al., 
2008). In the early stages of adipocyte differentiation, Trib3 expression is 
temporarily suppressed, which is necessary to relieve the inhibitory effect of 
TRIB3 on C/EBPβ and PPARγ, two transcriptional regulators that drive 
consecutive steps of the adipogenic differentiation cascade (Bezy et al., 2007; 
Takahashi et al., 2008). As with C/EBPβ (discussed in section 2.4.1.2), TRIB3 
inhibits PPARγ by binding to it and repressing its transcriptional activity 
(Takahashi et al., 2008). The downregulation of Trib3 in early adipogenesis 
also facilitates the activation of Akt kinase, a key event in adipocyte differenti-
ation (Naiki et al., 2007). Since the adipose tissue-specific Trib3 overexpression 
mouse line generated by Qi et al. (2006) utilizes a promoter construct that is 
only strongly activated starting from late adipogenesis, the phenotype of these 
mice is probably not informative with regard to the observed functions of Trib3 
in adipocyte differentiation (Takahashi et al., 2008).  
In light of these results, it is notable that standard diet-fed Trib3 knockout 
mice display unaltered body weight and body fat percentage, and their serum 
levels of triglycerides and free fatty acids are indistinguishable from wild type 
controls (Okamoto et al., 2007). Similarly, no difference in the protein level of 
ACC in adipose tissue was observed in standard chow diet-fed mice lacking 
Trib3 (Okamoto et al., 2007). Thus, Trib3 does not appear to have a non-
redundant role in mouse adipogenesis or fat metabolism in standard laboratory 
animal husbandry conditions. 
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2.4.3.4. Links between TRIB3 and the hematopoietic system 
There are multiple reports assigning different roles to TRIB3 in hematopoietic 
cells, and TRIB3 demonstrates interesting expression dynamics in hematopoietic 
processes; however, a comprehensive picture has yet to emerge. For example, in 
ex vivo models of erythropoiesis, Trib3 is upregulated in erythroblasts in 
response to the cytokine erythropoietin and promotes erythroid progenitor cell 
survival (da Cunha et al., 2010; Dev et al., 2010; Sathyanarayana et al., 
2008; Singh et al., 2012). In contrast, in an ex vivo model of human mega-
karyopoiesis, TRIB3 expression is repressed during the course of 
megakaryocyte differentiation (Ahluwalia et al., 2015).  
Regarding the very early stages of hematopoietic differentiation, the down-
regulation of Trib3 appears to be a requirement for the in vitro differentiation of 
hematopoietic progenitors from mouse embryonic stem cells (Roy et al., 2015). 
Going a stage forward from hematopoietic progenitors, to the myeloid 
commitment of mouse hematopoietic stem cells, involves a marked increase in 
Trib3 expression (Klimmeck et al., 2014). 
As mentioned in section 2.4.2.2, TRIB3 is not a leukemia oncogene, as 
opposed to TRIB1 and TRIB2, since TRIB3 does not trigger ubiquitination and 
degradation of C/EBPα, a transcription factor involved in myeloid differentia-
tion (Dedhia et al., 2010; Keeshan et al., 2006; Yokoyama et al., 2010; Yoshida 
et al., 2013). Transplantation of bone marrow overexpressing Trib1 or Trib2 
into lethally irradiated mice leads to the development of acute myeloid leuke-
mia, while mice transplanted with Trib3-overexpressing bone marrow do not 
display leukemogenesis and present normal spleen weight, white blood cell 
count, bone marrow blast proportion and overall survival (Dedhia et al., 2010). 
 
 
2.4.3.5. TRIB3 and the brain 
Little is known about the physiological importance of TRIB3 in the brain. 
Recent studies have reported that Trib3-deficient mice display no apparent 
alterations in the developmental apoptosis of neurons and present grossly 
normal anatomy and cellular content in the cortical and subcortical regions of 
the brain (Aime et al., 2015; Zareen et al., 2013). A human single-nucleotide 
polymorphism (dbSNP ID: rs6051520) located between TRIB3 and its 
neighboring gene, NRSN2, has been associated with information processing 
speed in a genome-wide association study (Luciano et al., 2011). The 
polymorphism is quite common, with a minor allele frequency slightly above 
0.2 in the Caucasian cohorts studied by Luciano et al. (2011), and is located 
approximately 9 kbp from the 5′-end of TRIB3 and approximately 16 kbp from 
the 3′-end of NRSN2. This polymorphism is also noteworthy because it is 
currently the only genome-wide association linked to TRIB3, according to the 
NHGRI-EBI Catalog of Published Genome-wide Association Studies (available 
at: www.ebi.ac.uk/gwas, accessed 2015-10-15; Welter et al., 2014). 
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2.4.3.6. Heterozygous TRIB3 loss-of-function  
appears to be tolerated in humans 
Through the ongoing progress of large-scale high-throughput sequencing 
projects, sufficient numbers of human exomes have now been acquired to 
evaluate which genes are subject to strong selective pressure against protein-
altering variants in the human population (Lek et al., 2015). In particular, the 
Exome Aggregation Consortium has presented an analysis of the genetic 
variance in the exome sequences of nearly 61,000 unrelated adults, with 
individuals affected by severe pediatric diseases excluded from the sample (data 
available at: exac.broadinstitute.org, accessed 2015-11-17; Lek et al., 2015). In 
this dataset, the number of loss-of-function, missense and synonymous variants 
observed in the TRIB3 gene corresponds closely to the number of variants 
expected by random mutation, indicating that a heterozygous loss of TRIB3 
function is tolerable in humans. No individuals with a disruption of both TRIB3 
alleles (i.e., knockout individuals) have been identified by the Exome 
Aggregation Consortium or by studies aimed at identifying human knockouts in 
specific populations (Narasimhan et al., 2016; Sulem et al., 2015); however, 
this is to be expected, based on the sample sizes used in the analyses and the 
allele frequencies of the observed TRIB3 loss-of-function alleles.  
Similarly, no TRIB1 or TRIB2 knockout humans have been reported by these 
studies (Lek et al., 2015; Narasimhan et al., 2016; Sulem et al., 2015). 
Remarkably though, in contrast to TRIB3, there appears to be a considerable 
intolerance towards a heterozygous loss of TRIB1 or TRIB2 in humans. The 
Exome Aggregation Consortium data (referenced above) reveals that TRIB2 is a 
possible haplo-insufficient gene, and TRIB1 loss-of-function variants also 
appear to be markedly under-represented. In the case of TRIB3, it can be 
proposed that the loss of one allele can be masked by the remaining functional 
allele, due to the existence of several negative feedback mechanisms that 
regulate TRIB3 transcription (Table 3). Additionally, since both healthy and 
diseased individuals (except severe pediatric disorder patients, as mentioned 
above) were included in the sample of exomes investigated by the Exome 
Aggregation Consortium, future studies that take into account disease-state may 
uncover associations between TRIB3 coding variation and disease susceptibility. 
 
 
2.4.4. TRIB3—a tumor suppressor or tumor-promoting gene? 
Multiple lines of evidence link TRIB3 to cancer development, progression and 
metastasis. However, there are also indications that TRIB3 may act as an anti-
tumor factor. In light of such apparently contradictory results, the question 
stated in the heading of this section arises. Which way is it then, is TRIB3 a 
tumor promoter or suppressor? Intriguingly, current research suggests that a 
single answer may indeed be inadequate; TRIB3 could be both. 
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2.4.4.1. TRIB3 is overexpressed in several types of cancer  
and its expression level is linked to disease prognosis 
Overexpression of TRIB3 compared to normal tissue has been reported in many 
types of human tumors. TRIB3 protein levels have been found to be elevated in 
colorectal, liver and lung cancer (Hua et al., 2015b; Miyoshi et al., 2009; Zhou 
et al., 2013a), and TRIB3 mRNA overexpression has been reported in colorec-
tal, breast, lung, uterine, ovarian and esophagus cancer (Bowers et al., 2003; 
Miyoshi et al., 2009; Xu et al., 2007; Zhou et al., 2013a).  
Significantly, a high level of intra-tumor TRIB3 protein expression is 
associated with poor prognosis in colorectal, liver and lung cancer patients (Hua 
et al., 2015b), and high intra-tumor TRIB3 mRNA expression is correlated with 
poor prognosis in patients with colorectal, lung or breast cancer (Miyoshi et al., 
2009; Wennemers et al., 2011a; Wennemers et al., 2011b; Zhou et al., 2013a). 
Curiously, while high TRIB3 mRNA expression was found to be associated 
with poor prognosis, a high level of TRIB3 protein expression was found to 
denote good prognosis in the same cohort of breast cancer patients (Wennemers 
et al., 2011b). As mentioned in section 2.2.2, TRIB3 is post-translationally 
regulated by variation of its protein stability, depending on the cellular context. 
In the case of breast cancer patients, the research shows that TRIB3 mRNA and 
protein levels in tumor material often do not correlate with each other 
(Wennemers et al., 2011b; Wennemers et al., 2012). On the other hand, in colo-
rectal cancer patients, an association exists between the levels of TRIB3 mRNA 
and protein in tumor samples (Miyoshi et al., 2009). 
As with many regions of human chromosome 20, the TRIB3 gene locus is 
relatively frequently increased in copy number in colorectal tumors; for 
instance, TRIB3 copy number gain was detected in 10 out of 64 colorectal 
cancer samples (Ali Hassan et al., 2014) and in 16 out of 40 colon tumor 
samples (Loo et al., 2013). Thus, gains in TRIB3 gene copy number could 
contribute to increased TRIB3 expression in some tumors and may represent an 
advantageous genomic alteration for cancer cells, taking into account the 
association between TRIB3 expression level and poor prognosis that has been 
reported in several types of cancer (referenced above). 
In general, proto-oncogenes can become oncogenes due to increased expres-
sion levels or protein-altering mutations (Kumar et al., 2015). In an analysis of 
somatic point mutations in nearly 5,000 human cancer exomes, the TRIB3 
coding sequence in cancers was not mutated significantly differently from the 
background expectation (data available at: www.tumorportal.org, accessed 
2015-10-15; Lawrence et al., 2014). However, Lawrence et al. (2014) do note 
that the power of their analysis is considerably limited by the currently available 
sample size; thus, while somatic alterations to the TRIB3 protein sequence are 
not currently suspected to be clinically relevant to cancer, this view may need to 
be revised following future studies. 
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2.4.4.2. TRIB3 as a modulator of the cellular  
stress response in tumor tissue 
The interior regions of solid tumors often represent a harsh microenvironment 
in which cells suffer from a multitude of different stresses, including hypoxia, 
nutrient deprivation and ER stress (Fukumura et al., 2010; Hirayama et al., 
2009; Tameire et al., 2015). This may underlie the overexpression of TRIB3 in 
tumors, since such stresses lead to the transcriptional induction of TRIB3 
(discussed in section 2.3). Subsequently, stress-induced TRIB3 can potentially 
regulate the cellular stress response and positively or negatively affect cell 
viability by the mechanisms described in section 2.4.1. For example, TRIB3 
expression in breast cancer tissue co-localizes with hypoxic regions, and, in 
breast cancer cells, the knockdown of TRIB3 expression decreases resistance to 
hypoxia (Wennemers et al., 2011a). In another instance, glutamine deficiency 
occurring in in vivo models of neuroblastoma leads to the induction of TRIB3, 
and the increased level of TRIB3 participates in the promotion of cell death and 
thereby inhibits tumor growth (Qing et al., 2012). 
 
 
2.4.4.3. TRIB3 may suppress tumor initiation 
By studying Trib3 knockout mice using multiple models of tumorigenesis, 
Salazar et al. (2015) have demonstrated that endogenous TRIB3 suppresses 
tumor formation. In a tumor engraftment experiment using Ras/E1A-trans-
formed mouse embryonic fibroblasts, the transplantation of Trib3−/− cells result 
in the accelerated onset of tumor growth, compared to Trib3+/+ cells (Salazar et 
al., 2015). Using an in vivo chemical carcinogenesis model of skin cancer 
development, Salazar et al. (2015) also show that malignant skin lesions arise 
with greater frequency in Trib3-deficient mice. Further, by crossing Trib3 
knockout mice with mice genetically predisposed to tumor development due to 
mono-allelic loss of PTEN (Pten+/− mice), it was demonstrated that the loss of 
Trib3 increases the incidence of premalignant and malignant lesions on a Pten+/− 
genetic background (the whole-body loss of Trib3 alone did not increase the 
baseline incidence of such lesions) (Salazar et al., 2015). The anti-tumorigenic 
effect of Trib3 was found to involve the suppression of Akt activation by 
TRIB3, and, in the absence of Trib3, increased Akt activity led to enhanced 
inactivation of FoxO3, a tumor-suppressing transcription factor (Salazar et al., 
2015). Thus, endogenous Trib3 can inhibit cancer initiation by limiting Akt-
driven tumorigenesis. 
Pathologic conditions involving a chronic inflammatory state can eventually 
lead to the development of cancer in the affected part of the body; examples of 
such conditions include hepatitis C and B, Helicobacter pylori gastritis, gastric 
acid reflux esophagitis and inflammatory bowel disease (Kumar et al., 2015). 
As will be described in section 2.4.5, TRIB3 may act as a suppressor of inflam-
mation in some such conditions, thereby potentially attenuating carcinogenesis 
that is driven by a chronic inflammatory state. 
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2.4.4.4. TRIB3 may potentiate tumor progression 
Countering the anti-cancer roles described in the previous section, several 
lines of inquiry have revealed that Trib3 can promote tumor growth and 
metastasis by a number of mechanisms. Specifically, Trib3 overexpression 
was found to increase tumor incidence in a chemical carcinogenesis model of 
lung and liver tumor formation, and, in allograft/xenograft experiments with 
melanoma, liver and colon cancer cells, the depletion of TRIB3 inhibited 
tumor growth rate as well as the formation of metastatic nodules (Hua et al., 
2015b). These effects were found to be linked to the suppression of 
autophagic flux by TRIB3 via an interaction between TRIB3 and SQSTM1, 
and treatment with a peptide engineered to disrupt the TRIB3–SQSTM1 
interaction inhibited xenograft tumor growth and metastasis (Hua et al., 
2015b). 
Endogenous TRIB3 has also been found to increase the growth rate of human 
breast cancer xenograft tumors, potentially by activating Notch, a mediator of 
breast cancer progression, metastasis and recurrence (Izrailit et al., 2013).  
In vitro, TRIB3 knockdown has an inhibitory effect on breast cancer cell 
proliferation, and this effect depends on a reduction of Notch pathway activity 
by the TRIB3 silencing (Izrailit et al., 2013). Similarly, TRIB3 depletion in a 
lung cancer cell line leads to decreased cell viability and migration with a 
concurrent decrease in Notch expression (Zhou et al., 2013a).  
TRIB3 promotes Notch activity in breast cancer cell lines by activating the 
MAPK–ERK and TGF-β–SMAD4 pathways (Izrailit et al., 2013). Interestingly, 
TRIB3 potentiates TGF-β signaling in breast cancer cells by stabilizing SMAD4 
via a mechanism that is independent of SMURF1 or SMURF2, two ubiquitin 
ligases that TRIB3 interacts with in order to regulate several other SMAD 
proteins (Chan et al., 2007; Hua et al., 2011; Izrailit et al., 2013). The 
regulation of MAPK–ERK activity by TRIB3 possibly takes place via its 
interactions with the MAPK cascade members MEK1 and MLK3 (Chadee and 
Kyriakis, 2004; Humphrey et al., 2010; Kiss-Toth et al., 2004).  
An additional mechanism by which TRIB3 may support tumor progression 
is through the positive regulation of TGF-β–SMAD3 activity (Hua et al., 2011). 
Through SMAD3, endogenous TRIB3 enhances cell migration and invasion in 
in vitro assays, and, in hepatoma cell culture, endogenous TRIB3 contributes to 
the epithelial–mesenchymal transition, a process that promotes the initiation of 
metastasis by enabling cancer cell invasion (Hua et al., 2011).  
Taken together, these results demonstrate that Trib3 has the potential to 
support tumor growth and progression by mechanisms that include the atten-
uation of autophagy and the positive regulation of signaling pathways, such as 
TGF-β and Notch signaling. 
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2.4.4.5. The potential for cell cycle control by TRIB3 
It is also possible that TRIB3 participates in cell cycle control, a major function 
of Drosophila Tribbles (Grosshans and Wieschaus, 2000; Mata et al., 2000; 
Seher and Leptin, 2000). In different cell lines, TRIB3 has been reported to 
either accelerate (Hua et al., 2015b; Izrailit et al., 2013; Miyoshi et al., 2009; 
Sakai et al., 2013), decelerate (Salazar et al., 2015; Selim et al., 2007) or have 
no effect (Örd et al., 2007; Schwarzer et al., 2006) on the rate of cell 
proliferation.  
In a case where TRIB3 was found to impede cell proliferation, the overex-
pression of TRIB3 induced a cell cycle delay in the G2 phase and inhibited the 
promoter of Cyclin B1, a factor required for transitioning through G2 (Morse et 
al., 2009; Selim et al., 2007). These effects could be mediated by the interaction 
between TRIB3 and CDC25A, a phosphatase that activates the G2/M cell cycle 
transition (Sakai et al., 2010). TRIB3 also interacts with CtIP, a transcriptional 
co-repressor involved in cell cycle checkpoint control (Xu et al., 2007).  
In an instance of cell proliferation acceleration by TRIB3, the over-
expression of TRIB3 was associated with elevated Cyclin D1 and B1 expression 
levels and also with an increased appearance of polyploidization (Sakai et al., 
2013). Conversely, TRIB3 is also implicated in the maintenance of genome 
integrity by interacting with APOBEC3A and reducing its ability to edit nuclear 
DNA and induce double-strand DNA breaks (Aynaud et al., 2012), though the 
role of TRIB3 in limiting APOBEC3A activity has been contested (Land et al., 
2013). 
 
 
2.4.4.6. TRIB3 may mediate cell sensitivity to chemotherapeutics 
TRIB3 expression is upregulated in response to some of the chemotherapeutic 
compounds currently used or being investigated, as noted in section 2.3.2. 
Furthermore, in some cases the expression of TRIB3 is required for the 
compounds to effectively kill cancer cells. TRIB3 is known to mediate the anti-
cancer actions of cannabinoids in glioma and hepatocellular carcinoma cell lines 
by causing the inhibition of the Akt–mTORC1 axis (Salazar et al., 2009b; 
Salazar et al., 2013; Vara et al., 2011). A similar TRIB3-mediated molecular 
mechanism is thought to underlie the cell death-inducing effect of salinomycin, 
a novel potent anti-cancer compound, in lung cancer cells (Li et al., 2013).  
In both the case of cannabinoids as well as salinomycin, TRIB3 expression is 
activated in response to treatment-induced ER stress (Li et al., 2013; Salazar et 
al., 2009b). Further examples of TRIB3-dependent anti-cancer therapeutics are 
the perifosine–sorafenib combination of kinase inhibitors in lymphoma cell 
lines (Locatelli et al., 2013), the PPARα/γ activator ABTL0812 in lung and 
pancreatic cancer cell lines (Erazo et al., 2015), and the NF-κB inhibitor 
DHMEQ in hepatoma cell lines (Lampiasi et al., 2009; Lampiasi et al., 2012; 
Lampiasi et al., 2014). Notably, DHMEQ also upregulates TRIB3 expression by 
inducing ER stress (Lampiasi et al., 2009). TRIB3 has a dichotomous effect on 
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cell sensitivity to the combination of celecoxib and MG132 (inhibitors of 
cyclooxygenase-2 and the proteasome, respectively), since the presence of 
TRIB3 either increases or decreases combination-induced cell death, depending 
on the hepatoma cell line investigated (Cusimano et al., 2010). 
 
 
2.4.5. Roles for TRIB3 in inflammatory diseases 
2.4.5.1. TRIB3 as an inflammation modulator through NF-κB 
TRIB3 is engaged in limiting inflammatory processes by attenuating NF-κB 
activity (Duggan et al., 2010; Olah et al., 2014; Smith et al., 2011), though 
examples of positive modulation of the NF-κB pathway by TRIB3 have also 
been reported (Fang et al., 2014; Yu et al., 2015).  
Helicobacter pylori infection can lead to gastric diseases, including stomach 
cancer, by a process thought to involve a chronic upregulation of inflammatory 
mediators (Kumar et al., 2015). TRIB3 is downregulated in gastric biopsies with 
H. pylori infection, and endogenous TRIB3 inhibits NF-κB transcriptional 
activity and chemokine transcription activation in response to H. pylori 
lipopolysaccharide, indicating that TRIB3 repression by H. pylori could 
contribute to H. pylori-associated pathogenesis (Smith et al., 2011).  
Chronic reflux of gastric contents into the esophagus generates a persistent 
inflammatory state that may lead to the development of Barrett’s esophagus, 
which can eventually progress to esophageal cancer (Kumar et al., 2015). 
TRIB3 is downregulated in Barrett’s esophagus tissue samples, compared to 
normal esophageal tissue, and endogenous TRIB3 inhibits NF-κB transcriptional 
activity as well as the expression of pro-inflammatory cytokines in esophageal 
cells, indicating that the decline of TRIB3 expression in Barrett’s esophagus 
may contribute to carcinogenesis (Duggan et al., 2010).  
The inhibition of NF-κB activity by TRIB3 is also thought to underlie the 
anti-inflammatory actions of cannabidiol, a non-psychotropic phytocannabinoid 
which has been studied as a potential therapeutic agent against acne vulgaris 
(Olah et al., 2014).  
Curiously, in osteoblastic cells treated with lipopolysaccharides extracted 
from Porphyromonas endodontalis, a bacterial pathogen associated with tooth 
pulp infections and inflammatory bone resorption, TRIB3 appears to potentiate 
the pro-inflammatory action of NF-κB (Yu et al., 2015), indicating that the 
relationship between TRIB3 and NF-κB activity is complex. 
 
 
2.4.5.2. Further links between TRIB3 and inflammation 
TRIB3 may also participate in inflammatory signaling by differentially 
modulating the activation of the different MAPK classes (ERK, JNK and 
p38), potentially through the physical interactions between TRIB3 and the 
MAPKKs MEK1 and MKK7 or between TRIB3 and the MAPKKK MLK3 
50 
(Humphrey et al., 2014; Kiss-Toth et al., 2004). Activator protein 1 (AP-1), 
a sequence-specific transcription factor of heterogeneous composition 
(homo- and heterodimers of bZIP proteins from the Jun, Fos, Maf and ATF 
families), is activated in response to various extracellular stimuli through 
MAPK signaling cascades (Shaulian and Karin, 2002; Uluckan et al., 2015). 
Potentially by interacting with MAPK pathway components, TRIB3 is able 
to inhibit AP-1 transcriptional activity in response to cytokine stimulation 
(Kiss-Toth et al., 2004). Additionally, TRIB3 is thought to reduce pro-
inflammatory cytokine gene expression in kidney cells and alleviate diabetic 
kidney disease by inhibiting the mTORC2–Akt pathway (Borsting et al., 
2014). 
Systemic sclerosis is a disorder characterized by fibrosis (excessive deposi-
tion of connective tissue) in the skin and other organs of the body, and is 
thought to be the result of chronic inflammation originating from autoimmunity 
(Kumar et al., 2015). Persistently activated TGF-β–SMAD signaling in fibro-
blasts drives the development of fibrosis, and TRIB3, which is overexpressed in 
the skin of systemic sclerosis patients, potentiates TGF-β-mediated activation of 
fibroblasts (Tomcik et al., 2016). Further, in mouse models of systemic 
sclerosis, skin fibrosis can be markedly alleviated by in vivo knockdown of 
Trib3 (Tomcik et al., 2016). 
In an association study based on a gene-centric microarray, a single-
nucleotide polymorphism (dbSNP ID: rs6139007) located less than 1 kbp 
upstream of major TRIB3 transcription initiation sites was associated with a 
modest effect on the concentration of circulating interleukin-6 (IL-6), a major 
pro-inflammatory cytokine (Shah et al., 2013). Interestingly, in a genome-wide 
linkage analysis for the discovery of autism spectrum disorder risk loci, the 
chromosomal region containing TRIB3 (20p13) revealed the strongest linkage 
signal, and the linkage peak is located at rs6139007 (Werling et al., 2014), the 
same TRIB3 upstream region variation identified in the IL-6 concentration study 
mentioned previously. 
 
 
2.4.6. TRIB3 in diabetes and its complications 
2.4.6.1. TRIB3 may contribute to insulin resistance  
as well as to the loss of pancreatic β-cells 
Type 2 diabetes, the most prevalent type of diabetes mellitus, is charac-
terized by insulin resistance—a reduced response to insulin in insulin-
sensitive tissues, including skeletal muscle, liver and adipose tissue (Kumar 
et al., 2015). In the aforementioned tissues, elevated TRIB3 mRNA 
expression has been found in humans and rodents with insulin resistance (Bi 
et al., 2008; Du et al., 2003; Liu et al., 2010; Oberkofler et al., 2010). As 
mentioned previously (2.4.1.3), TRIB3 has been reported to inhibit Akt 
kinase, a critical factor for insulin signaling, and thereby contribute to 
insulin resistance in the liver (Du et al., 2003). In the rat liver, TRIB3 is 
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acetylated and physically interacts with the histone acetyltransferase PCAF, 
and hypo-acetylation of TRIB3 has been proposed to potentiate the 
inhibition of Akt by TRIB3 (Yao and Nyomba, 2008).  
While Trib3-deficient mice display no detectable aberrations in insulin 
signaling when maintained under standard laboratory animal husbandry 
conditions (as discussed in section 2.4.3.1), Trib3 knockout mice maintained on 
a high-fat diet exhibit reduced skeletal muscle insulin resistance (Koh et al., 
2013). Similarly, in vivo silencing of Trib3 expression in mouse or rat models of 
type 2 diabetes results in improved insulin sensitivity (Ti et al., 2011; Wang et 
al., 2012; Weismann et al., 2011). Interestingly, mice engineered to overexpress 
Trib3 in skeletal muscle show normal skeletal muscle insulin signaling and 
glucose uptake (An et al., 2014). 
In the insulin signal transduction cascade, the binding of insulin to the insu-
lin receptor is followed by the activation (phosphorylation) of insulin receptor 
substrate (IRS) proteins, which proceed to activate further signaling pathways, 
such as the phosphoinositide 3-kinase (PI3K) pathway, in which Akt is consid-
ered to be the principal effector (Kumar et al., 2015). Besides interacting with 
and inhibiting Akt, a recent report suggests that TRIB3 additionally inhibits 
insulin signaling upstream of Akt by interacting with and inhibiting the activa-
tion of IRS1 (Koh et al., 2013). 
Insulin is secreted by pancreatic β-cells, and TRIB3 has also been reported to 
impair insulin secretion by inhibiting insulin exocytosis (Liew et al., 2010). 
Further, excessive Trib3 expression can also harm pancreatic β-cell viability, as 
mice genetically engineered to overexpress Trib3 in pancreatic β-cells display 
reduced β-cell mass and proliferation at older ages, along with decreased 
glucose tolerance and glucose-stimulated insulin secretion (Liew et al., 2010). 
Trib3 has been reported to potentiate β-cell apoptosis that is induced by ER 
stress (Fang et al., 2014) or elevated concentrations of free fatty acid (Qin et al., 
2014), conditions that contribute critically to the development of β-cell insuffi-
ciency in type 2 diabetes (Cnop et al., 2005). Additionally, pancreatic islets 
isolated from Trib3-deficient mice display reduced susceptibility to cytokine-
induced β-cell death in an ex vivo model of the autoimmune β-cell destruction 
that occurs during the pathogenesis of type 1 diabetes (Humphrey et al., 2014). 
 
 
2.4.6.2. The effect of TRIB3 on diabetes complications 
Diabetic kidney disease is a common complication of longstanding diabetes 
(Kumar et al., 2015), and the role of TRIB3 in the development of diabetic 
nephropathy has also been studied. Trib3−/− mice with diabetes induced by 
streptozotocin, a compound that causes pancreatic β-cell destruction, develop 
more severe kidney dysfunction than Trib3+/+ mice, indicating a protective 
effect of TRIB3 in the diabetic kidney (Borsting et al., 2014). This effect is 
thought to involve the attenuation of mTORC2-mediated Akt activation in the 
kidney by the binding of TRIB3 to the mTORC2 components mTOR and 
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RICTOR (Borsting et al., 2014). On the other hand, studies involving the in 
vivo knockdown of Trib3 in rats with either streptozotocin-induced diabetes or 
high-fat diet-induced insulin resistance indicate that TRIB3 supports the devel-
opment of diabetic renal pathology (Ding et al., 2014; Wang et al., 2014). The 
divergent effects of TRIB3 may be due to the peculiarities of the different dis-
ease models and whether Trib3 was silenced after the onset of disease or had 
been constitutively knocked out. As a gene implicated in insulin signaling, 
Trib3 could also alter the underlying metabolic disorder that leads to the kidney 
pathology being investigated. Notably, in the study of diabetic nephropathy in 
mice with streptozotocin-induced diabetes, the level of hyperglycemia was 
similarly severe in Trib3 knockout and wild type mice (Borsting et al., 2014). 
Diabetes also increases the risk of cardiovascular disease, and, in a mouse 
model of diabetic atherosclerosis, in vivo silencing of Trib3 reduced the extent 
of atherosclerotic plaques and improved plaque stability (Wang et al., 2012); 
therefore, Trib3 potentially increases the risk of acute myocardial infarction. 
Further, following an experimental myocardial infarction, mice with cardiac 
muscle-specific overexpression of Trib3 develop more extensive damage to the 
heart than wild type mice (Avery et al., 2010). Pathological cardiac remodeling 
can involve cardiomyocyte loss due to excess mechanical stress, and TRIB3 has 
been uncovered as a major contributor to stretch-induced cardiomyocyte apop-
tosis (Cheng et al., 2015). Based on in vivo gene silencing experiments, Trib3 is 
also implicated in the development of diabetic cardiomyopathy, a deterioration 
of heart function that develops as a complication of prolonged diabetes but is 
not explained by coronary artery disease (Ti et al., 2011). The beneficial effects 
of Trib3 silencing on diabetic atherosclerosis and diabetic cardiomyopathy may 
be mediated in part by improved metabolic status, as Trib3 silencing also 
resulted in markedly improved control of blood glucose (Ti et al., 2011; Wang 
et al., 2012).  
 
 
2.4.6.3. A common, non-synonymous TRIB3 variant  
associated with human diseases: the Q84R substitution 
In human TRIB3, a non-synonymous single-nucleotide polymorphism that 
results in the substitution of glutamine at position 84 of the TRIB3 protein with 
arginine (Q84R) has been described (dbSNP ID: rs2295490, alleles: A/G on the 
forward strand of the chromosome and also on the sense strand of the gene; 
Prudente et al., 2005). This genetic variation is relatively common, with the 
minor allele (G, corresponding to TRIB3 R84) having an overall frequency of 
0.20 in a global sample of 2504 people from 26 populations (The 1000 
Genomes Project, Phase 3, May 2013 call set; Auton et al., 2015). The human 
minor allele is actually the ancestral variant, and the arginine encoded by it is 
conserved in human TRIB1 and TRIB2, mouse TRIB1, TRIB2 and TRIB3, and 
Drosophila Tribbles (Hegedus et al., 2007).  
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Human TRIB3 R84 is considered a gain-of-function variant since it confers 
TRIB3 with a superior ability to bind Akt and inhibit insulin-stimulated Akt 
phosphorylation (i.e., activation), compared to the TRIB3 Q84 variant 
(Andreozzi et al., 2008; Formoso et al., 2011; Liew et al., 2010; Prudente et al., 
2005). Based on molecular modeling, the Q84R substitution is thought to cause 
structural differences in the Akt-interacting region (Andreozzi et al., 2008). 
Additionally, the TRIB3 R84 protein demonstrates a prolonged half-life 
compared to TRIB3 Q84 (Liew et al., 2010).  
In human populations, the TRIB3 R84 variant is associated with a number of 
health issues, including reduced insulin sensitivity, impaired insulin secretion, 
type 2 diabetes, metabolic syndrome, abdominal obesity, hypertriglyceridemia, 
atherosclerosis, insulin resistance-related myocardial infarction, and type 2 
diabetes-related kidney disease (Bacci et al., 2013; De Cosmo et al., 2007; 
Formoso et al., 2011; Gong et al., 2009; Liew et al., 2010; Prudente et al., 
2005; Prudente et al., 2009; Prudente et al., 2010; Prudente et al., 2013; Shi et 
al., 2009; Zhang et al., 2015). The TRIB3 Q84R polymorphism has not been 
examined in microarray-based large-scale genome-wide association studies of 
type 2 diabetes or related traits, since this particular polymorphism has not been 
included the experimental designs and is not linked to any of the analyzed 
polymorphisms, precluding allele inference (Bacci et al., 2013; Liew et al., 
2010; Prudente et al., 2010; Prudente et al., 2013). Thus, the associations 
between TRIB3 position 84 variants and abnormalities of glucose homeostasis 
require further validation in large-scale studies in order to achieve ‘genome-
wide significance’ (Prudente et al., 2012). 
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3. AIMS OF THE PRESENT STUDY 
In Drosophila, Tribbles is a developmentally important protein that inhibits 
mitosis. In mammals, the fruit fly tribbles gene has three homologs, TRIB1, 
TRIB2 and TRIB3, which appear to have been repurposed over the course of 
evolution. TRIB3 has acquired distinct expression characteristics, displaying 
mRNA upregulation in response to cellular stress in a wide variety of cell types, 
and although numerous roles associated with stressful conditions as well as 
normal physiology have already been attributed to TRIB3, there still remains 
much to be learned about the functions of the TRIB3 gene. 
 
The specific aims of this work are the following: 
 
 to design and validate an experimental approach for comparing the 
abundance of human TRIB3 mRNA variants, 
 to characterize the composition of the human TRIB3 mRNA population 
under normal and stressful conditions, 
 to analyze the expression of Trib3 in mouse bone marrow-derived mast cell 
(BMMC) cultures responding to mast cell biology-related signals (such as 
stimulation by the growth factor IL-3, sensitization by IgE and the induction 
of degranulation by antigen), 
 to determine the capability of Trib3-deficient BMMCs to perform 
immunological functions (such as degranulation and activation-induced 
cytokine mRNA expression), 
 to examine the expression of Trib3 and the other tribbles homologs during 
the course of mouse brain development and in different regions of the adult 
mouse brain, 
 to uncover if a lack of Trib3 affects mouse behavioral responses that are 
dependent on the eIF2α–ATF4 pathway, which TRIB3 is known to inhibit in 
cell culture experiments, 
 to elucidate the mechanism that leads to TRIB3 upregulation in glucose-
starved cells, 
 to investigate the effect of TRIB3 on the transcriptional response to glucose 
deprivation, using genome-wide gene expression analysis, and 
 to shed light on the mechanism how elevated TRIB3 expression affects the 
viability of cells subjected to glucose-deficient conditions. 
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4. RESULTS AND DISCUSSION 
 4.1. Development of an assay system for the comparative 
quantification of human TRIB3 mRNA isoforms (Ref. I) 
A previous study by our group uncovered the existence of several human TRIB3 
mRNA isoforms, which are generated by the use of alternative transcription 
initiation sites and alternative splicing of the first exon (Örd and Örd, 2005). In 
all cases, the first TRIB3 exon encompasses precisely the mRNA 5′-UTR and 
the second exon begins with the translation initiation codon (as described in 
section 2.3.5). As a result, the 5′-UTR sequence can vary completely between 
the different TRIB3 mRNA isoforms, while the encoded TRIB3 protein is 
predicted to be identical in all cases (Örd and Örd, 2005). Since the properties 
of the 5′-UTR play a principal role in determining the rate of protein synthesis 
from an mRNA molecule, variation of the 5′-UTR can affect gene expression at 
the translational level (Hughes, 2006; Kozak, 2005). Additionally, alternative 
mRNA 5′-end regions may arise through the activation of alternative promoters 
and thereby signify a mode of transcriptional regulation (Hughes, 2006). 
In order to achieve a better understanding of TRIB3 gene expression regula-
tion, a project was initiated to characterize the composition of the TRIB3 mRNA 
pool in cells subjected to regular or stressful conditions. To enable this, a re-
verse transcription-quantitative polymerase chain reaction (RT-qPCR) system 
that allows the comparative quantification of the different TRIB3 mRNA 
isoforms was designed and validated. In the assay system, template amplifica-
tion is detected by SYBR Green I dye binding to double-stranded DNA, the 
PCR product. The five different splice variants of exon 1 (1A, 1B1, 1B2, 1B3 
and 1B4) are quantified using RT-qPCR amplicons consisting of a splice 
variant-specific primer that binds to the exon 1–exon 2 junction and a common 
primer that binds to the invariant exon 2 sequence. Additionally, since the exon 
1A transcription initiation sites span a region of several hundred base pairs, 
three amplicons were positioned along the exon 1A sequence to distinguish 
splice variant 1A 5′-UTRs with a minimal length of either 184, 283 or 343 
nucleotides (sequence lengths are based on a TRIB3 allele that contains two 
copies of the polymorphic 33-bp tandem repeat discussed in section 2.3.3.1). 
Finally, a primer pair targeting the TRIB3 protein-coding region, which is 
common to all TRIB3 mRNA isoforms, was used to acquire the total TRIB3 
mRNA level. 
The specificity of each isoform-specific amplicon toward its target isoform 
was assessed by qPCR, using plasmids that contained the cDNA of either the 
target or non-target TRIB3 mRNA variants as reaction templates. RT-qPCR 
results obtained with different amplicons are initially not directly comparable to 
each other, due to technical reasons arising from the qPCR step (such as 
different reaction amplification efficiencies for different primer pairs and 
differences in the amount of fluorescent dye bound per product molecule) and 
especially from the reverse transcription step (variable efficiency of reverse 
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transcription in different mRNA regions due to inefficient priming or mRNA 
secondary structures that inhibit reverse transcriptase progression) (Stahlberg et 
al., 2004; Stangegaard et al., 2006; Vandenbroucke et al., 2001; Zhang and 
Byrne, 1999). Thus, several additional methodological steps were required to 
obtain RT-qPCR-based data that allows for the comparison of the abundances 
of the different TRIB3 mRNA isoforms. Plasmid-based standard curves were 
used to correct for the differences originating from the qPCR step, and the 
reverse transcription efficiencies of the different TRIB3 amplicon regions were 
determined by quantifying the reverse transcription of in vitro-synthesized full-
length human TRIB3 mRNA spiked into mouse total RNA. 
 
 
4.2. Cellular stress alters the composition of the  
TRIB3 mRNA population in human hepatoma cells,  
potentiating protein production (Ref. I) 
HepG2 human hepatocellular carcinoma cells were selected to be the subject of 
the TRIB3 mRNA isoform quantification, since these cells display readily 
detectable basal TRIB3 mRNA expression and robust TRIB3 induction in 
response to stress (Örd and Örd, 2005), and they have been used extensively as 
a model system for eIF2α–ATF4 pathway-based stress responses (for example, 
Shan et al., 2010). Additionally, the liver is a major site of TRIB3 expression in 
the body (discussed in section 2.3.1), and HepG2 cells have retained a 
considerable degree of hepatocyte metabolism and gene expression (Javitt, 
1990; Tyakht et al., 2014). To activate ATF4-mediated cellular stress responses, 
the cells were treated with arsenite, a known inducer of oxidative stress, protein 
misfolding and eIF2α phosphorylation (Bernstam and Nriagu, 2000; Brostrom 
et al., 1996; Zhou et al., 2008a). 
The results reveal that in HepG2 cells incubated in normal growth medium, 
the predominant TRIB3 mRNA splice variant is 1A, which constitutes slightly 
over 90% of the TRIB3 mRNA population, and the remainder is mostly made 
up of 1B4 (8%), while the splice variants 1B1, 1B2 and 1B3 together account 
for less than 1% of the mRNA population. In response to arsenite treatment, the 
overall level of TRIB3 mRNA is upregulated 23-fold. The splice variants 1A, 
1B1, 1B2 and 1B3 are all induced by around 20-fold, while splice variant 1B4 
is upregulated more than 50-fold. Thus, in arsenite-treated cells, splice variant 
1A remains predominant and 1B1–1B3 remain marginal, but the prevalence of 
1B4 increases substantially (to 15%) in stressed cells as a consequence of the 
more prominent induction of 1B4 compared to other splice variants. 
The TRIB3 C/EBP–ATF composite site, which mediates TRIB3 gene induc-
tion in response to stress, is located in 33-bp tandem repeats that are situated 
192 bp upstream of the exon 1A splice donor site. RT-qPCR results obtained 
with amplicons corresponding to different regions of exon 1A uncovered that 
under normal growth conditions, around half of the 1A mRNAs are generated 
using transcription start sites located upstream of the 33-bp repeat region, while 
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only around 10% are initiated downstream of the 33-bp repeats. These 
proportions are drastically altered in response to arsenite stress: the percentage 
of 1A mRNAs extending upstream of the 33-bp repeats is diminished (to 
approximately 3%) and the percentage of 1A mRNAs initiated downstream of 
the 33-bp repeats rises to above 80%. Thus, the upregulation of TRIB3 mRNA 
level in response to stress is mainly achieved by the production of splice variant 
1A mRNAs with shortened 5′-UTRs, due to the preferential use of transcription 
start sites located downstream of the 33-bp repeat regions, while splice variant 
1A mRNAs with long 5′-UTRs initiated upstream of the 33-bp repeats 
contribute significantly to the TRIB3 mRNA pool under basal conditions. 
Results obtained by D. Örd (presented in Ref. I) reveal that splice variant 1A 
mRNAs with short 5′-UTRs are translated two-fold more efficiently in HepG2 
cells than those with long 5′-UTRs. Strong mRNA secondary structures formed 
from GC-rich sequences in 5′-UTRs impair translation (Babendure et al., 2006; 
Kozak, 1989; Pickering and Willis, 2005), and both long and short forms of 
human TRIB3 splice variant 1A mRNA 5′-UTRs display nearly 80% GC con-
tent, which is above the human average of around 60% (Kalari et al., 2006; 
Pesole et al., 2001). Additionally, the long forms of TRIB3 splice variant 1A  
5′-UTRs contain two short ORFs that are situated upstream of the TRIB3 
protein-coding ORF. These 5′-UTR elements, termed ‘upstream ORFs’ 
(uORFs), are present in more than 40% of human mRNAs (Peri and Pandey, 
2001) and may inhibit the translation of the protein-coding ORF by directing 
ribosomes to initiate translation from the uORF start codon, provided that the 
uORF start codon is in a favorable nucleotide context for translation initiation 
(Kozak, 2001; Wang and Rothnagel, 2004). The initiation codon of one of the 
TRIB3 uORFs is in an optimal context for translation initiation (Kozak, 1986; 
Kozak, 1987), and further experiments performed by D. Örd (Ref. I) uncovered 
that the inclusion of this uORF underlies the different translational efficiencies 
of the long and short forms of TRIB3 splice variant 1A mRNAs. 
Taken together, the results of Ref. I indicate that transcriptional and transla-
tional mechanisms act in concert to facilitate the upregulation of TRIB3 in 
response to arsenite-induced cellular stress in HepG2 cells. In arsenite-treated 
cells, TRIB3 transcription initiation sites are shifted downstream compared to 
untreated cells, leading to an increased proportion of TRIB3 mRNAs with splice 
variant 1B4 and short 1A 5′-UTRs. As a result of this shift, stress-induced 
TRIB3 transcription is predominantly initiated downstream of the 33-bp tandem 
repeats which contain the stress-responsive C/EBP–ATF composite sites 
(described in section 2.3.3.1).  
Variation of the first exon is often associated with alternative promoter usage 
(for example, Holthuizen et al., 1993; Hughes and Brady, 2005; Martineau et 
al., 2004; Sobczak and Krzyzosiak, 2002), and the distribution of the TRIB3 
transcription start sites over a range of roughly 500 bp is compatible with the 
concept of multiple core promoters, since human core promoters typically 
utilize transcription initiation sites spread over 50–100 bp (Sandelin et al., 
2007). As discussed in section 2.3.3.1, C/EBP–ATF composite sites themselves 
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are flexible regarding positional requirements and satisfy the criteria for 
classification as enhancers. Arsenite-treated HepG2 cells preferentially induce 
TRIB3 splice variant 1A mRNAs that contain a truncated 5′-UTR, which boosts 
protein synthesis due to the lack of an inhibitory uORF. Elimination of an 
inhibitory uORF by 5′-UTR truncation has also been described for some other 
genes (Blaschke et al., 2003; Phelps et al., 1998).  
Future studies quantifying TRIB3 mRNA isoforms are warranted in order to 
uncover the cell- and stress-type specificity of the TRIB3 mRNA variant profile. 
In addition to differentially containing uORFs, TRIB3 5′-UTRs are GC-rich and 
presumably impede translation also by forming secondary structures. It may be 
worth investigating whether TRIB3 mRNAs are subject to context-dependent 
derepression by increased translation initiation factor eIF4E activity, which 
alleviates the inhibitory effects of GC-rich 5′-UTRs (Koromilas et al., 1992; 
Nikolcheva et al., 2002; Rosenwald, 2004). 
 
 
4.3. Trib3 expression in mouse bone marrow-derived  
mast cells (BMMCs) is upregulated by interleukin 3 (IL-3),  
a major mast cell growth factor (Ref. II) 
Mast cells are tissue-resident immune cells that serve as the principal effector cells 
for immunoglobulin E (IgE)-mediated acquired immune responses and also 
participate in innate immune responses (Galli et al., 2005). Mast cells are critical for 
providing host defense against helminthic parasites in the intestine; however, they 
are also central for the manifestation of allergic disorders (Abraham and St. John, 
2010; Kumar et al., 2015). Mast cells are characterized by the presence of a large 
number of cytoplasmic granules that are filled with pro-inflammatory mediators 
such as histamine (Galli et al., 2005). Upon activation, mast cells rapidly secrete the 
preformed inflammatory mediators stored in their granules (‘degranulation’) and 
subsequently proceed to release newly-formed lipid-derived mediators (such as 
prostaglandins and leukotrienes), cytokines (including TNF, IL-1β and IL-6) and 
chemokines (Abraham and St. John, 2010; Galli et al., 2005). 
Developmentally, mast cells are hematopoietic cells and thus originate from 
bone marrow; however, mature mast cells ordinarily do not circulate in the 
blood, even though mast cells are widely distributed in tissues (Ribatti and 
Crivellato, 2014). Rather, mast cell precursors circulate in low numbers and 
enter peripheral tissues, where they complete their differentiation and remain as 
long-lived cells (Abraham and St. John, 2010). Chief factors driving mast cell 
proliferation and maturation in mice are stem cell factor and IL-3 (Ribatti and 
Crivellato, 2014). The injection of IL-3 into mice dramatically increases the 
number of mast cells (Abe et al., 1988; Metcalf et al., 1986), and IL-3 knockout 
mice display a profound attenuation of mast cell hyperplasia in response to 
intestinal nematode infection, along with delayed clearance of the infection 
(Lantz et al., 1998). In vitro, culturing mouse bone marrow cells in the presence 
of IL-3 can be used to produce an ample and high-purity supply of mast cells 
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(Jensen et al., 2006). These cells, termed BMMCs, are widely used to study 
mast cell function in vitro (Jensen et al., 2006) and are even suitable for 
reconstituting mast cell populations in mice genetically lacking mast cells 
(Grimbaldeston et al., 2005; Wolters et al., 2005). 
TRIB3 has previously been implicated in mediating the response to erythro-
poietin, the principal cytokine controlling erythrocyte production, in erythroid 
progenitors (Sathyanarayana et al., 2008). Additionally, high Trib3 expression 
has been noted in bone marrow (Kiss-Toth et al., 2004), and roles in normal 
hematopoiesis and/or hematopoietic malignancy have been uncovered for Trib1 
and Trib2 (Stein et al., 2015). While TRIB3 has been implicated in the regula-
tion of inflammatory processes (discussed in section 2.4.5), little is known 
about the importance of TRIB3 in immune cells, including mast cells. 
In Ref. II, BMMCs derived from wild type mice were used to study whether 
Trib3 expression is modulated by treatments that generate mast cell-specific 
responses. Mast cells are primed to react to a specific antigen (‘sensitized’) by 
the binding of IgE to the high-affinity IgE receptor (Abraham and St. John, 
2010). IgE binding also enhances mast cell survival (Asai et al., 2001). Mast 
cells are activated (that is, triggered to secrete inflammatory mediators) when a 
multivalent antigen concurrently binds to multiple IgE molecules, resulting in 
the cross-linking of IgE receptor molecules (Abraham and St. John, 2010). In 
BMMCs, the Trib3 mRNA level is not altered in response to sensitization, and 
BMMC activation leads to a modest decrease in Trib3 expression.  
After Ref. II had been submitted, Kuo et al. (2012) published gene 
expression microarray results showing that Trib3 is prominently upregulated in 
response to IgE sensitization in RBL-2H3 rat basophilic leukemia cells 
expressing human chemokine receptor 1 (RBL-CCR1) (the effect of IgE 
receptor cross-linking on Trib3 expression was not analyzed). They also present 
data that in RBL-CCR1 cells sensitized with IgE, Trib3 inhibits cytokine 
production (Kuo et al., 2012). However, the effect of Trib3 on the response to 
IgE receptor cross-linking (i.e., activation), which dramatically increases 
cytokine production beyond the level generated by IgE treatment alone 
(Koranteng et al., 2004), was not examined (Kuo et al., 2012). RBL-2H3 cells 
have some mast cell-like and some basophil-like characteristics, and have 
undergone malignant transformation, including constitutive activation of growth 
factor receptor signaling (Passante and Frankish, 2009; Passante et al., 2009; 
Tsujimura et al., 1995). For these reasons, they are considered problematic as a 
model of primary mast cell physiology (Jensen et al., 2006; Passante and 
Frankish, 2009). Indeed, Kuo et al. (2012) compare their RBL-CCR1 IgE 
sensitization gene expression microarray results to results obtained using 
primary human mast cells (analyzed in Jayapal et al., 2006) and note that there 
is no overlap between the two cell types in the genes that are induced at least 
two-fold by IgE sensitization (Kuo et al., 2012). 
BMMCs are dependent of IL-3 for proliferation and survival, and, as demon-
strated in Ref. II, the removal of IL-3 from the growth medium causes a decline 
in Trib3 expression, which is reversible by the re-addition of IL-3. Since IL-3 
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can elicit a wide range of gene expression alterations by affecting mRNA turn-
over (Ernst et al., 2009), the level of unspliced Trib3 precursor mRNA was 
quantified as a proxy for the rate of gene transcription (Lipson and Baserga, 
1989). The results reveal that Trib3 pre-mRNA is also induced by IL-3, 
indicating regulation at the transcriptional level. Thus, Trib3 gene activation is 
positively regulated in BMMCs by IL-3, their requisite cytokine. 
There are few previous reports of TRIB3 regulation by hematopoietic 
growth factors. In an erythroleukemia cell line, TRIB3 was found to be down-
regulated in response to the withdrawal of granulocyte-macrophage colony-
stimulating factor (GM-CSF) (Lin et al., 2007), a cytokine which shares a 
common receptor with IL-3 (Martinez-Moczygemba and Huston, 2003). Down-
stream of its receptor, IL-3 modulates at least three major signaling pathways: 
Jak/STAT, MAPK and PI3K (Martinez-Moczygemba and Huston, 2003). Of 
these pathways, positive regulation of Trib3 has been associated with the 
activity of STAT5 downstream of erythropoietin and PI3K downstream of 
insulin (Ding et al., 2008; Sathyanarayana et al., 2008). Both STAT5 and PI3K 
are known to be critical for IL-3 signaling and functional effect in BMMCs (Ali 
et al., 2004; Shelburne et al., 2003), and could prove to convey the effect of  
IL-3 on the Trib3 gene.  
Besides Trib3, several other cellular stress-inducible genes, such as Atf3, 
Atf5 and Xbp1, are also positively regulated by IL-3 in cells of hematopoietic 
origin (Gilchrist et al., 2010; Kurata et al., 2011; Persengiev et al., 2002), and 
the upregulation of these genes by IL-3 could indicate that stress response 
pathways are utilized to maintain the physiology of cytokine-stimulated cells. 
Particular immune cell functions are certainly known to require the integrated 
stress response pathway (Mielke et al., 2011; Scheu et al., 2006), for which 
Trib3 (as discussed in section 2.3.3) as well as Atf3 and Atf5 are downstream 
targets (Deval et al., 2009; Pan et al., 2007; Shan et al., 2009; Shan et al., 
2010).  
 
 
4.4. Lack of Trib3 impairs BMMC  
immunological functions (Ref. II) 
Our group has generated a novel mouse line carrying a targeted deletion of 
Trib3 (first described in Ref. II). In these mice, the entire Trib3 protein-coding 
region, which spans from exon 2 to exon 4, has been eliminated, thereby 
precluding the production of truncated protein forms. The absence of Trib3 has 
been confirmed using several approaches (Refs. II and III). In line with the 
Trib3 knockout mouse line derived independently by Okamoto et al. (2007), 
homozygous Trib3 null individuals from our mouse line are viable and physi-
cally grossly normal.  
To study the importance of Trib3 in mast cells, BMMCs were derived from 
Trib3-deficient mouse bone marrow. The development of mast cells from bone 
marrow cell culture can be monitored by periodically examining the cells for 
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the presence of mature mast cell surface markers using flow cytometry (Jensen 
et al., 2006). Experiments performed by D. Örd (Ref. II) indicate that in the 
absence of Trib3, the kinetics of BMMC differentiation in IL-3-supplemented 
medium are unaltered, and that the mature mast cell populations produced from 
Trib3−/− bone marrow cultures are similar to Trib3+/+ cultures in cell quantity, 
purity and IgE receptor expression level. To evaluate the functional capabilities 
of the BMMCs, the cells were sensitized using IgE that is specific to dinitro-
phenyl (a synthetic antigen) and subsequently activated with the corresponding 
multivalent antigen, dinitrophenyl-conjugated bovine serum albumin. Following 
activation, the extent of BMMC degranulation was determined by measuring 
the release of β-hexosaminidase, an enzyme present in mast cell granules and 
involved in anti-bacterial defense (Fukuishi et al., 2014; Schwartz et al., 1979), 
and the induction of cytokine production was quantified by monitoring the 
mRNA levels of TNF and IL-6, two important cytokines secreted by activated 
mast cells (Abraham and St. John, 2010). 
The results reveal that Trib3-deficient BMMCs display an impairment of 
degranulation as well as cytokine gene upregulation in response to IgE-
mediated activation. Their ability to degranulate is compromised over a wide 
range of antigen concentration, and also when BMMC activation is induced by 
pharmacological means that bypass the IgE receptor altogether.  
In light of these results, in vivo assessment of dermal mast cell activity was 
carried out using a passive cutaneous anaphylaxis assay, which measures dye 
extravasation into tissue as a result of vasodilation caused by mast cell 
degranulation. In this model, there is no apparent difference between Trib3+/+ 
and Trib3−/− mice. It is possible that compensatory mechanisms are acting in 
vivo to mask the effect of Trib3 deficiency in skin mast cells or that the role of 
Trib3 is limited to certain mast cell subtypes. There are two major 
phenotypically distinct types of mast cells in the mouse: connective tissue-type 
mast cells, such as those in the skin, and mucosal-type mast cells, such as those 
in the intestinal mucosa (Gurish and Austen, 2012). The mast cells that arise 
from culturing mouse bone marrow cells in medium supplemented with IL-3 
largely resemble the mucosal type (Gurish et al., 1992; Jensen et al., 2006), 
highlighting that an in vivo examination of mucosal mast cells in Trib3 
knockout mice may also be warranted. 
Currently, it remains unknown how Trib3 deletion leads to defects in 
BMMC function. Recent reports suggest that in some situations, TRIB3 
supports the activation of NF-κB (Fang et al., 2014; Yu et al., 2015). In 
BMMCs, NF-κB activation mediates the induction of the cytokines TNF and 
IL-6 in response to IgE receptor cross-linking; however, NF-κB activity is 
dispensable for BMMC degranulation, which Trib3 deletion also affects in 
addition to cytokine induction (Marquardt and Walker, 2000; Peng et al., 2005). 
BMMCs appear to require the induction of autophagy for degranulation (Ushio 
et al., 2011), and, in glioma cells, TRIB3 can potentiate autophagy by reducing 
mTORC1 activity (Salazar et al., 2009a), thereby providing a possible 
mechanism for the degranulation defect resulting from Trib3 gene disruption. 
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Note that cytokine induction is unaffected in autophagy-defective BMMCs 
(Ushio et al., 2011). Recent reports have uncovered that TRIB3 binds to 
RICTOR and possibly decreases its function (Borsting et al., 2014), and that 
endogenous RICTOR is a suppressor of mast cell activation (Smrz et al., 2014). 
Modulation of RICTOR by TRIB3 could partly, but not entirely, explain the 
potentiation of BMMC activation by Trib3, since RICTOR acts in an IgE 
receptor-specific manner (Smrz et al., 2014), while the effect of Trib3 is also 
evident when proximal IgE receptor signaling is bypassed. 
The quite broad impairment of immunological functions in Trib3 knockout 
BMMCs is consistent with a signaling defect that is situated relatively down-
stream in the mast cell activation signaling cascade (Baba et al., 2008; 
Nechushtan et al., 2000). Growth factors can assert even broader effects on 
cells, and the major growth factor for BMMCs, IL-3, is known to affect not only 
mast cell development, proliferation and survival but also immunological 
responses (Coleman et al., 1993; Gebhardt et al., 2002; Mekori et al., 1993; 
Minks et al., 1992). Experiments performed by D. Örd and included in Ref. II 
show that Trib3-deficient BMMCs are more sensitive to IL-3 deprivation than 
wild type BMMCs, displaying delayed cell cycle resumption following short-
term transient IL-3 deficiency and accelerated cell death during prolonged IL-3 
withdrawal. Thus, Trib3−/− BMMCs appear more susceptible to inadequate 
growth factor action than Trib3+/+ BMMCs, which could also underlie the 
reduced responsiveness of Trib3-deficient BMMCs to immunological 
stimulation. If this is the case, Trib3 may be induced by IL-3 (described in 
section 4.3) in order to potentiate certain aspects of IL-3 signaling, such as the 
preservation of mast cell function and viability. Therefore, the effector 
pathways downstream of the IL-3 receptor warrant further investigation in order 
to elucidate the signals leading to BMMC Trib3 expression as well as to 
determine the contribution of TRIB3 to IL-3 signaling. 
 
 
4.5. Trib3 expression increases during mouse brain  
development and Trib3−/− mice display enlarged  
lateral ventricles in the brain (Ref. III) 
The sole tribbles gene in Drosophila encodes a developmental regulatory protein 
(as discussed in section 2.1); however, the knockout mice for the mammalian 
tribbles genes appear physically grossly normal (discussed in section 2.4.3.1). Trib3 
was initially isolated from neuronal cell cultures (Mayumi-Matsuda et al., 1999; 
Örd and Örd, 2003) and was subsequently found to directly inhibit ATF4 (Bowers 
et al., 2003; Örd and Örd, 2003). In addition to playing a central role in the 
mammalian cellular stress response, ATF4 (alias CREB2, cAMP response element-
binding protein 2) has also been described as a suppressor of CREB-dependent 
memory formation, based on work originally done in the sea slug Aplysia 
californica (Bartsch et al., 1995; Karpinski et al., 1992). Therefore, the 
characterization of the role of Trib3 in the brain was initiated. 
63 
First, to study the course of tribbles homolog gene expression during brain 
development, RT-qPCR was used to analyze Trib1, Trib2 and Trib3 mRNA 
levels in the mouse brain (sans cerebellum) from embryonic day (E) 14 to post-
natal day (P) 4. The typical gestation period for laboratory mice is 19–20 days 
(Hedrich, 2004). The results show that Trib3 expression increases steadily in the 
mouse brain from E14 to E18, amounting in total to an upregulation of 
approximately 4-fold. After birth (at P0), the Trib3 mRNA level appears to 
decrease somewhat; however, the expression level recovers by P2, reaching 
nearly 6-fold above the E14 level, and remains high at P4. In comparison, the 
expression of both Trib1 and Trib2 remains relatively steady during brain 
development, with expression levels varying less than 2-fold over the entire 
period from E14 to P4. Additionally, it seems that there is no compensatory 
upregulation of Trib1 or Trib2 expression in the brain in response to a lack of 
Trib3, as an analysis of P3 mouse brains revealed no differences in Trib1 or 
Trib2 expression levels between Trib3+/+, Trib3+/− and Trib3−/− mice. Based on 
these results, Trib3 deficiency could affect mouse brain development. 
Since nerve growth factor deprivation induces Trib3 (Angelastro et al., 
2000; Mayumi-Matsuda et al., 1999; Zareen et al., 2013), the elevation of Trib3 
mRNA level in the developing brain could originate from excess neurons that 
are suffering from neurotrophic factor deficiency and will eventually undergo 
apoptosis in order to be removed, a characteristic feature of vertebrate brain 
development (Blaschke et al., 1996; Oppenheim, 1991). In addition to neuronal 
cells, microglial cells can also express Trib3 (Juknat et al., 2012; Juknat et al., 
2013). Thus, the cell type and circumstances generating Trib3 expression in the 
developing brain await further investigation.  
An examination of adult Trib3 knockout mouse brain morphology, 
performed by K. Lilleväli and T. Tekko and included in Ref. III, revealed no 
apparent alterations to the gross morphology of prominent brain structures, 
except for a tendency towards larger lateral ventricle size in Trib3-deficient 
individuals. This trend was subjected to further investigation by measuring 
the lateral ventricle area from coronal sections of Trib3+/+ and Trib3−/− 
mouse brains. Two independent groups of Trib3+/+ and Trib3−/− mice were 
studied: an adult group, consisting of individuals approximately 6 months of 
age, and a juvenile (P9) group. The results demonstrate that in both groups, 
lateral ventricle size is significantly increased in Trib3-deficient individuals 
(by 1.5-fold in adults and 2-fold in juveniles). This suggests that Trib3 
affects the ventricular system of the brain but not other major anatomical 
structures. 
The ventricles of the brain are a network of four chambers that are filled 
with cerebrospinal fluid, and the two lateral ventricles, which are the largest, 
form arc-shaped chambers in either cerebral hemisphere (Saladin, 2003). The 
interior surfaces of the ventricles are responsible for producing cerebrospinal 
fluid, which serves to provide neutral buoyancy and basic protection for the 
brain (Saladin, 2003). Although lateral ventricle size in humans increases with 
age and is linked to age-related brain disorders (Skullerud, 1985), it is also quite 
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variable among healthy, non-elderly people (Allen et al., 2002). Similarly, brain 
ventricle size varies between different strains of laboratory mice, and the 
C57BL/6 strain, which the Trib3 knockout mouse used in Ref. III is based upon, 
exhibits a moderate lateral ventricle size (Hino et al., 2009). Extreme enlarge-
ment of ventricles is seen in hydrocephalus, which is caused by excessive 
cerebrospinal fluid accumulation (Kumar et al., 2015). The occurrence of 
congenital hydrocephalus is increased in the C57BL/6J strain of mice compared 
to several other strains, but the incidence is still low (0.029% according to data 
available at: www.jax.org/news-and-insights/2003/july/hydrocephalus-in-
laboratory-mice, accessed 2015-11-24). No young Trib3 knockout mice have 
presented with overt hydrocephalus, though the sample size is insufficient to 
rule out a minor increase in susceptibility (data not shown). In the future, it 
could be worthwhile to study whether aging-related ventricular expansion is 
affected by Trib3 deficiency. 
 
 
4.6. Amino acid-imbalanced diet induces Trib3  
in the mouse brain but Trib3 is not essential for  
the aversive reaction to such diet (Ref. III) 
In the mammalian brain, the eIF2α–ATF4 pathway is implicated in several 
behavioral processes. Essential amino acids (EAAs) are the amino acids that 
must be obtained from the diet because they cannot be synthesized de novo by 
the body (Saladin, 2003). Many foods contain EAAs in suboptimal proportions, 
and omnivores have evolved a mechanism to detect if a food source provides an 
inadequate amount of one or more EAAs, and they try to correct the imbalance 
by consuming a combination of different foods (Gietzen et al., 2007). In a 
laboratory setting, this effect is evident when mice or rats are presented a diet 
that lacks a single EAA but is otherwise nutritionally complete; the animals will 
limit their intake of such a diet and search for alternative dietary sources 
(Gietzen et al., 2007). This innate reaction takes place already during the first 
meal and is dependent on the sensing of serum amino acid levels by a specific 
region of the brain, the anterior piriform cortex (APC), but does not depend on 
taste, smell or gastrointestinal signals (Gietzen et al., 2007).  
At the molecular level, the eIF2α kinase GCN2 senses the amino acid deficit 
through the resulting accumulation of uncharged tRNA molecules and proceeds 
to phosphorylate eIF2α in the APC (Hao et al., 2005; Koehnle et al., 2004; 
Maurin et al., 2005). Crucially, mice with a deletion of Gcn2 fail to reject the 
EAA-insufficient diet; however, processes taking place downstream of eIF2α 
phosphorylation in this context are not well described (Hao et al., 2005; Maurin 
et al., 2005). Since TRIB3 is able to provide negative feedback of the eIF2α–
ATF4 pathway in EAA-deprived cell cultures (Jousse et al., 2007), experiments 
were carried out to determine if Trib3 participates in the APC-dependent 
aversive reaction to EAA-insufficient diet. 
65 
To determine the expression level of Trib3 in different regions of the adult 
brain, and whether Trib3 is induced in response to an EAA-deficient diet, 
animals accustomed to a nutritionally complete synthetic diet were presented 
with either the same complete diet or a corresponding leucine-free diet for 6 h, 
and, subsequently, Trib3 expression was analyzed from excised brain tissue 
using RT-qPCR. The results show that in complete diet-fed mice, the APC, the 
frontal cerebral cortex and the hippocampus have very similar levels of Trib3 
expression. However, in mice fed the leucine-deficient diet, Trib3 expression is 
upregulated 3-fold specifically in the APC. The cerebellum displays a high level 
of Trib3 expression, which is unaffected by diet type. For comparison, the 
expression levels of Trib1 and Trib2 were also analyzed. Trib1 and Trib2 
display relatively uniform levels of expression across the examined brain 
regions, and neither of them is affected by diet composition in any of the brain 
regions. Thus, Trib3 has the most distinctive adult brain gene expression pattern 
of the three tribbles genes, with high basal expression in the cerebellum and 
diet-responsive expression in the APC. 
Recently, the Allen Brain Atlas project published an extensive gene expres-
sion analysis of the human brain, providing genome-wide gene expression data 
at an exceptionally high anatomical resolution, with approximately 500 samples 
collected per brain hemisphere per donor (data available at: www.brain-
map.org, accessed 2015-12-07; Hawrylycz et al., 2015). To evaluate the 
biological importance of a gene for brain processes, Hawrylycz et al. (2015) 
analyzed the extent of reproducible (conserved) structural patterning of gene 
expression across brain regions, a metric which ranked TRIB3 among the top 
15% most relevant genes. The expression pattern of TRIB3 in the human brain 
is characterized by a high level of expression in the cortex of the cerebellum, 
and a moderate and uniform expression level across different regions of the 
cerebral cortex—trends which are in excellent agreement with the mouse brain 
data obtained and presented in Ref. III. Additionally, the Allen Brain Atlas data 
reveals exceptionally low TRIB3 expression in the corpus callosum, the largest 
white matter structure in the human brain. Since the corpus callosum is rich in 
glial cells, while grey matter structures are rich in neuron bodies, the expression 
pattern of TRIB3 points to it being expressed in neuronal cells as opposed to 
glial cells. 
To assess the importance of Trib3 for the rejection of EAA-deficient diet, a 
method adapted from Maurin et al. (2005) was used. Prior to the experiment, 
adult Trib3+/+ and Trib3−/− mice were trained to a cycle of 12 h night-time fast-
ing–12 h day-time feeding with synthetic diet. During the experiment, the intake 
of either synthetic leucine-free diet or control (nutritionally complete) synthetic 
diet was measured for each animal at the 0.5, 1, 2, 4 and 12 h time-points. The 
results reveal that both genotypes exhibit a similar degree of EAA-deficient diet 
rejection, consuming approximately 30% less of the leucine-free diet than the 
control diet. The self-imposed food intake restriction is apparent already at the 
earliest time-point, 30 minutes, and is sustained at a similar level throughout 
the feeding period. The extent of the food intake decrease is similar to that 
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observed by Maurin et al. (2005) for their wild type mice. To assure that the 
food consumption data from Trib3+/+ and Trib3−/− mice are comparable, their 
baseline body weights and the amount of weight lost during overnight fasting 
were also measured, revealing that these traits are not altered by Trib3-
deficiency. Hence, it appears that although an EAA-insufficient diet markedly 
induces Trib3 in the mouse APC, the location of the brain’s chemosensor for 
EAA deficiency, a lack of Trib3 is inconsequential for the avoidance of EAA-
insufficient diet.  
It seems probable that the induction of Trib3 in the APC during EAA defi-
ciency is mediated by C/EBP–ATF composite site-driven transcription down-
stream of the GCN2–eIF2α–ATF4 pathway, since the phosphorylation of eIF2α 
in EAA-deficient APC has been established (Hao et al., 2005; Maurin et al., 
2005) and eIF2α phosphorylation-mediated Trib3 upregulation has been veri-
fied in several other types of cells (described in section 2.3). Notably, there is 
little previous knowledge concerning the transcriptional responses of the APC 
to EAA-incomplete feeding, and it would be interesting to perform a broader, 
transcriptomic analysis. Functionally, aside from TRIB3, negative feedback 
regulation of the eIF2α–ATF4 pathway is also known to be provided by 
GADD34, a phosphatase regulatory subunit which directs eIF2α dephosphory-
lation (Ma and Hendershot, 2003). Currently, it cannot be excluded that alterna-
tive mechanisms of limiting eIF2α–ATF4 pathway activity are masking the 
effect of Trib3 deletion, thereby enabling normal aversive behavior towards 
EAA-insufficient diet in Trib3−/− mice. 
 
 
4.7. Trib3 is dispensable for long-term spatial  
memory and fear conditioning (Ref. III) 
In addition to the sensing of amino acid deficiency in the APC region of the 
brain, the eIF2α–ATF4 pathway is also known to be involved for other cogni-
tive processes, particularly hippocampus-dependent long-term memory for-
mation, such as spatial memory. Behavioral training reduces eIF2α phosphory-
lation in the hippocampus, and, in mouse models with decreased hippocampal 
phospho-eIF2α, ATF4 is downregulated and the threshold for long-term spatial 
memory formation is lowered (Costa-Mattioli et al., 2005; Costa-Mattioli et al., 
2007). Notably, increasing hippocampal eIF2α phosphorylation to an intermedi-
ate level that induces ATF4 but does not repress general translation is sufficient 
to impair hippocampus-dependent learning (Jiang et al., 2010). These results 
indicate that ATF4 activity in the hippocampus negatively regulates long-term 
spatial memory, which suggests the possibility that endogenous regulators of 
ATF4 activity, such as TRIB3 (which is expressed in the hippocampus, as noted 
in section 4.6), could influence the response to behavioral training. 
To examine the effect of Trib3 deletion on hippocampus-dependent spatial 
learning and memory, Trib3+/+ and Trib3−/− mice were compared in the Morris 
water maze experiment, a swimming-based navigation task where mice learn to 
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escape from the water by climbing onto a hidden platform located in a particular 
position in the pool (Morris et al., 1982). Multiple training sessions are 
performed on consecutive days, and the time the mice take to reach the platform 
(the ‘escape latency’) on each training event is monitored (Morris et al., 1982). 
The results reveal that the escape latencies of Trib3-deficient mice and wild 
type mice are similar across the entire four-day course of the experiment, with 
both genotypes demonstrating good learning ability. To further assess learning, 
a ‘probe trial’ was performed subsequently by removing the platform from the 
pool and monitoring the swimming trajectory of the mouse for one minute. In 
this test, both genotypes exhibited a similar, strong preference for the region of 
the pool that previously contained the hidden platform. Performance in the 
Morris water maze can be confounded by differences in locomotor ability, and 
the cerebellum, which coordinates muscular activity, expresses a relatively high 
level of Trib3 mRNA (as noted in section 4.6). An analysis of the swimming 
speeds of Trib3+/+ and Trib3−/− mice indicates that Trib3-deficiency does not 
compromise locomotor activity. Thus, the Morris water maze results demon-
strate that a lack of Trib3 does not significantly alter spatial learning ability in 
mice. 
After the mice have been subjected to the basic Morris water maze task 
described above, the platform can be repositioned and the mice can be 
challenged to relearn the location of the platform (‘reversal learning’), a test of 
behavioral flexibility (Vorhees and Williams, 2006). Interestingly, forebrain-
specific deletion of the eIF2α kinase PERK, which results in decreased ATF4 
abundance, does not affect standard Morris water maze learning but impedes 
reversal learning (Trinh et al., 2012). Therefore, Trib3+/+ and Trib3−/− mice were 
also subjected to the reversal learning procedure following the main Morris 
water maze experiment. However, neither the reversal training escape latencies 
nor the reversal probe trial results revealed any significant differences between 
the genotypes. 
The eIF2α phosphorylation pathway is also involved in long-term fear 
memory (Costa-Mattioli et al., 2005; Costa-Mattioli et al., 2007; Zhu et al., 
2011). Fear memory is commonly studied by ‘fear conditioning’: evaluating 
how readily animals learn to associate an unpleasant stimulus (e.g., an electric 
shock) with a neutral stimulus or context (e.g., an auditory tone or a particular 
chamber) (LeDoux, 2000). Fear conditioning requires the amygdala, and 
contextual fear conditioning additionally requires the hippocampus, while 
auditory fear conditioning does not (LeDoux, 2000). To study the role of Trib3 
in fear memory, auditory and contextual fear conditioning experiments were 
performed with Trib3+/+ and Trib3−/− mice, using the incidence of freezing 
behavior (immobility) to measure conditioned fear. For both types of fear 
conditioning, the results show a normal fear reaction in Trib3-deficient mice, 
suggesting that Trib3 does not affect long-term fear memory. 
It is an unexpected finding that the deletion of Trib3 does not affect long-
term spatial memory, spatial relearning or fear conditioning, a set of behavioral 
processes for which the involvement of eIF2α pathway activity modulation has 
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been previously established (Costa-Mattioli et al., 2005; Costa-Mattioli et al., 
2007; Jiang et al., 2010; Trinh et al., 2012; Zhu et al., 2011). A further eIF2α 
pathway-dependent cognitive function, the ability to sense amino acid imbal-
ance in food, was also unaffected by a lack of Trib3 (as discussed in section 
4.6). These behavioral paradigms address various regions of the brain, including 
the hippocampus, the amgydala and the APC.  
It is possible that in the brain, during a normal physiological state, TRIB3 is 
not a sufficiently potent regulator of the eIF2α–ATF4 pathway to affect 
behavioral responses. Moreover, the role of phospho-eIF2α and ATF4 in long-
term memory also appears to be more complex than initially thought, as several 
recent reports suggest positive instead of negative regulation of long-term 
memory by ATF4, alluding that the intricacies of the genetic models and 
experimental protocols used in different studies may play a significant role (Ill-
Raga et al., 2013; Pasini et al., 2015; Wei et al., 2012). Unfortunately, 
constitutive Atf4 knockout mice are unsuitable for many behavioral 
experiments, since they are effectively blind, have bone defects and display 
decreased body size (Hettmann et al., 2000; Masuoka and Townes, 2002; 
Tanaka et al., 1998; Yang et al., 2004).  
In addition to the behavioral data reported in the current work, the 
International Mouse Phenotyping Consortium has recently released data on the 
performance of Trib3 knockout mice in a different set of behavioral experiments, 
which are not centered on eIF2α pathway-dependent behavioral paradigms, and 
reports that no significant genotype effects were found (data available at: 
www.mousephenotype.org, accessed 2015-10-29, database release 3.4; Koscielny 
et al., 2014). Still, Trib3 may be important for behavioral responses that are 
currently unexplored or during the presence of aggravating circumstances, such as 
aging, nutritional deficiencies or diseases. 
 
 
4.8. ER stress-mediated ATF4 induction leads to TRIB3 
upregulation in response to glucose deprivation (Ref. IV) 
Glucose deficiency is a cell death-inducing stress that may occur in the context 
of several diseases. For instance, in a mouse model of stroke, the concentration 
of glucose in the infarction core region decreases to more than 10-fold below 
baseline (Kiewert et al., 2010). A glucose-deficient microenvironment is also 
characteristic to the interior regions of solid tumors, due to inefficient tumor 
vasculature, excessive cell proliferation and the abnormal metabolism of trans-
formed cells (Fukumura et al., 2010; Gillies et al., 2008; Hirayama et al., 2009). 
For example, the glucose level in human colon cancer tissue is on average  
10-fold below that of normal colon tissue, while the amino acids levels are 
comparable between tumor and normal tissues or even elevated in the tumor 
tissue (Hirayama et al., 2009). Malignant cells display a propensity to utilize 
glucose at a high rate and to metabolize it by aerobic glycolysis (Gillies et al., 
2008; Hanahan and Weinberg, 2011). This metabolic preference renders cancer 
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cells susceptible to compounds which inhibit glycolysis and thereby effectively 
evoke glucose deficiency (El Mjiyad et al., 2011). Therefore, the cellular stress 
response to glucose deficiency is potentially important for the progression of 
acute ischemic diseases, tumor growth and anti-cancer therapy. 
Since TRIB3 is cellular stress-associated regulatory protein (2.4.1) that is 
overexpressed in many types of human tumors and linked to cancer patient 
prognosis (2.4.4.1), an investigation into the role of TRIB3 during glucose 
deprivation was initiated. HEK293-derived cells were selected for analysis, 
since HEK293 cells exhibit a highly glycolytic metabolic phenotype—
comparable to cancer cells—when grown under standard conditions, consuming 
glucose at a rate 7-fold greater than the next most utilized carbon source and 
converting most intracellular pyruvate into lactate (Henry et al., 2011). The  
T-REx-293 cell line, a derivative of the HEK293 that stably expresses the 
tetracycline (Tet) repressor protein, was used as the basis for the experiments to 
allow for Tet-activated gene expression. Based on the T-REx-293 cell line, cells 
with Tet-inducible human TRIB3 expression (TRIB3-293 cell line) and 
corresponding empty vector-transfected cells (Vector-293 cell line) were 
created (Örd et al., 2007). 
To determine if TRIB3 expression is altered in response to glucose defi-
ciency in HEK293 lineage cells, T-REx-293 cells were incubated in glucose-
free growth medium and TRIB3 mRNA expression was analyzed by RT-qPCR. 
The results show that following 3 h of glucose deprivation, TRIB3 mRNA 
induction is already detectable, and subsequently the level of TRIB3 expression 
increases further. The level of TRIB3 unspliced precursor mRNA, which was 
quantified as a measure of gene transcription rate (Lipson and Baserga, 1989), 
is also increased during glucose deprivation, indicating that TRIB3 is upregu-
lated by transcriptional activation. In line with these data, Western blot analysis 
performed by D. Örd and presented in Ref. IV reveals that the level of TRIB3 
protein is also strongly upregulated by glucose deficiency.  
Next, several experiments were performed to elucidate the mechanisms 
leading to TRIB3 induction in response to glucose deprivation. ATF4 is known 
to activate TRIB3 gene transcription during ER stress and arsenite stress via a 
C/EBP–ATF composite site located in the TRIB3 promoter region (Ohoka et al., 
2005; Örd and Örd, 2005). An analysis of ATF4 expression in T-REx-293 cells 
reveals that both the ATF4 protein and mRNA levels are upregulated during 
glucose starvation, raising the possibility that ATF4 also drives TRIB3 gene 
activation in response to glucose deficiency. To test whether ATF4 mediates 
TRIB3 activation in glucose-deprived cells, ATF4 knockdown experiments were 
carried out. In cells suffering from glucose deprivation, ATF4 silencing reduced 
the levels of TRIB3 mRNA as well as TRIB3 pre-mRNA, implicating ATF4 in 
the transcriptional activation of TRIB3 during glucose deficiency.  
Upregulation of the ATF4 protein level, a common response to diverse types 
of stress, is brought on by the phosphorylation of eIF2α (as described in section 
2.3.3.2). Elucidating which particular kinase carries out eIF2α phosphorylation 
in glucose-deprived T-REx-293 cells would shed light on which cellular 
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functions are perturbed by the stress. One of the four eIF2α kinases, PERK, is 
characteristically activated in response ER stress (Wek et al., 2006), a known 
possible consequence of glucose deficiency (El Mjiyad et al., 2011). 
Overexpression of BiP (also known as GRP78 and HSPA5), a major ER 
chaperone protein, has been previously described to as a means to mitigate ER 
stress (Dorner et al., 1992). In T-REx-293 cells, BiP overexpression blunted 
ATF4 protein induction in response to glucose withdrawal and also in cells 
treated with tunicamycin, a specific inducer of ER stress. Thus, ER stress is 
implicated in glucose deprivation-mediated ATF4 induction.  
To verify that PERK activity initiates the signal for ATF4 induction, the 
highly selective PERK inhibitor GSK2606414 was employed (Axten et al., 
2012). The results show that PERK inhibition diminishes ATF4 protein 
induction in response to glucose deprivation or tunicamycin treatment but not in 
response to methionine deprivation, which is known to induce ATF4 by 
activating a different eIF2α kinase, GCN2 (Wek et al., 2006). Concurrently, 
treatment with PERK inhibitor eliminates the upregulation of TRIB3 mRNA 
and pre-mRNA in glucose-starved or tunicamycin-treated cells. Thus, TRIB3 is 
induced in glucose-deprived T-REx-293 cells as a transcriptional target of the 
ER stress response pathway consisting of the ER stress sensor kinase PERK and 
its transcriptional effector, ATF4. 
 
 
4.9. Gene expression profiling of the pro-survival effect  
of TRIB3 in glucose-starved HEK293 cells (Ref. IV) 
Insufficient availability of glucose disturbs multiple distinct facets of cell 
physiology. For instance, the ATP level declines, causing bioenergetic stress, 
the NADPH level decreases, impairing the antioxidant response and leading to 
oxidative stress, and a shortage of intermediates for protein glycosylation 
generates ER stress (El Mjiyad et al., 2011). All of these manifestations of 
glucose starvation elicit responses from the cell and can conceivably contribute 
to cell death. Since TRIB3 has previously been found to affect the cellular 
responses to different types of stressful conditions (as discussed in section 
2.4.1), TRIB3 induction in glucose-deprived cells (noted above in section 4.8) 
could also signify an important regulatory role. 
Cell viability analysis performed by D. Örd and included in Ref. IV revealed 
that Tet-induced TRIB3 expression markedly increases TRIB3-293 cell survival 
during glucose starvation, while siRNA-mediated silencing of endogenous 
TRIB3 in T-REx-293 cells promotes glucose deprivation-induced cell death. In 
Vector-293 cells, Tet treatment did not alter cell survival (D. Örd, Ref. IV) and 
had no effect of the level of TRIB3 mRNA expression, indicating that Tet does 
not affect cell viability or TRIB3 expression by unspecific mechanisms. These 
results demonstrate that TRIB3 enhances the viability of HEK293-derived cells 
suffering from glucose deficiency.  
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To gain insight into the effects of glucose deprivation on HEK293 lineage 
cells and how TRIB3 promotes glucose-deprived cell survival, genome-wide 
gene expression profiling was performed in TRIB3-293 and Vector-293 cells 
that had been either treated with Tet or left Tet-untreated and either incubated in 
complete medium or glucose-free medium. Notably, TRIB3 exhibits nuclear 
localization and interacts with several cellular stress-associated transcription 
factors (as discussed in section 2.4.1), giving rise to the possibility of 
transcriptional effects. 
Remarkably, the results reveal that on a genome-wide scale, endogenous 
TRIB3 mRNA ranks as the most highly glucose deprivation-regulated 
transcript. Overall, approximately 300 genes are upregulated and nearly 270 
are downregulated by at least 2-fold in response to glucose starvation in 
HEK293-derived cells. These gene sets were analyzed with bioinformatical 
tools in order to gain insight into the state of the cells. Gene Ontology term 
enrichment analysis (Reimand et al., 2011) was conducted for functional 
profiling of the genes, and transcription factor binding motif enrichment 
analysis (Janky et al., 2014) was used to uncover possible regulatory 
mechanisms.  
Among glucose deprivation-upregulated genes, the most prominent 
enrichment is revealed for ER stress response genes, in line with the notion of 
ER stress as a possible consequence of glucose deficiency (El Mjiyad et al., 
2011) and the root of glucose deprivation-induced TRIB3 upregulation (4.8). 
Amino acid metabolism genes are also markedly enriched among glucose 
starvation-induced genes, possibly as a result of ER stress-induced ATF4 
activating the amino acid availability program that it is known to control 
(Schroder and Kaufman, 2005; Siu et al., 2002). The most highly enriched 
transcription factor binding motif in genes upregulated by glucose deprivation is 
the motif shared by ATF and C/EBP transcription factors, implicating these 
factors as major direct activators of the transcriptional response to glucose 
starvation.  
On the other hand, glucose deprivation-downregulated genes are enriched 
for genes associated with cell cycle progression and display an over-
representation of E2F transcription factor binding motifs, consistent with the 
cessation of cell proliferation in growth medium lacking glucose and the 
participation of E2F family members in the control of cell cycle progression 
(Duronio and Xiong, 2013). 
To assess how elevated TRIB3 expression affects the transcriptional response 
to glucose deprivation, all genes regulated by glucose starvation were filtered 
for genes demonstrating at least a 1.5-fold expression change in response to Tet-
induced TRIB3 expression. According to these criteria, TRIB3 increases the 
expression of around 20 glucose deprivation-regulated genes, and a similar 
number of genes display an expression decrease. Among the glucose starvation-
regulated genes that are also TRIB3-regulated, the direction of the TRIB3 effect 
tends to be towards the alleviation of the glucose deprivation-induced gene 
expression change. Notably, less than 10% of all glucose deprivation-regulated 
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genes are affected by TRIB3, indicating that TRIB3 is not a general regulator of 
the transcriptional response to glucose starvation but rather may perform a more 
targeted role. 
Among the TRIB3-downregulated genes, functional profiling reveals an 
enrichment of amino acid metabolism-associated genes and transcription factor 
binding motif analysis predicts that the majority of the TRIB3-downregulated 
genes are target genes of ATF4. As discussed previously, TRIB3 is an inhibitor 
of ATF4 (2.4.1.1), which serves as the master activator of amino acid supply 
genes (Shan et al., 2009). Thus, the results indicate that the predominant 
mechanism of TRIB3-mediated gene repression is the inhibition of ATF4. 
Curiously, ATF4 activity induces cell death during ER stress by increasing 
overall protein synthesis (Han et al., 2013). However, the determination of the 
overall protein synthesis rate in TRIB3-293 cells by 35S-methionine/cysteine 
pulse-labeling suggests that elevated TRIB3 expression does not suppress cell 
death by an effect on overall protein synthesis. 
Aside from the amino acid metabolism genes, the candidate TRIB3-
regulated genes belong to diverse functional categories, including a number of 
genes that participate in other aspects of metabolism and several genes involved 
in cell communication. The gene that demonstrates the greatest expression 
sensitivity to TRIB3 is the TGF-β superfamily member inhibin βE (INHBE), 
which is expressed at a nearly 3-fold lower level in the presence of Tet-induced 
TRIB3 in glucose-deprived TRIB3-293 cells. In comparison, the greatest 
TRIB3-mediated upregulation is seen for insulin-like growth factor-binding 
protein 2 (IGFBP2) mRNA, which is expressed at a level approximately  
2.4-fold higher in glucose-deprived TRIB3-293 cells treated with Tet than in 
cells without Tet. Additionally, it is noteworthy that TRIB3-sensitive genes did 
not include classical cell death regulator genes, such as caspases or BCL2 
family members. 
 
 
4.10. Elevated TRIB3 expression alleviates the glucose 
deprivation-induced downregulation of IGFBP2, a novel  
glucose deficiency survival factor (Ref. IV) 
One of the genes that demonstrated relatively substantial TRIB3-dependence in 
the expression profiling experiment (described in the previous section) was 
IGFBP2. Humans have a total of six genes that encode IGFBPs, which bind the 
growth factors IGF-I and IGF-II in plasma, decreasing IGF availability but 
increasing its half-life (Baxter, 2014). Through this mode of action, IGFBPs can 
affect IGF receptor-dependent events such as IGF-induced cell proliferation 
(Hoflich et al., 1998). However, IGFBPs also serve a range of IGF-independent 
roles, which may be intracellular as well as extracellular (Baxter, 2014).  
In particular, the IGF-independent actions of IGFBP2 include suppressing 
apoptosis by reducing caspase-3 activity (Migita et al., 2010) and potentiating 
cell motility by activating integrin signaling (Schutt et al., 2004). Clinically, 
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IGFBP2 is overexpressed in several types of human tumors, such as colorectal, 
breast, gastric, esophageal, pancreatic and ovarian cancer, glioma and leukemia 
(Busund et al., 2005; Chen et al., 2006; Fuller et al., 1999; Mishra et al., 1998; 
Wang et al., 2006; Warnecke-Eberz et al., 2015; Wex et al., 1998; Zhang et al., 
2007). Further, high in situ IGFBP2 levels in leukemia and glioma are linked to 
poor prognosis (Dawczynski et al., 2008; McDonald et al., 2007), and high 
plasma IGFBP2 concentration is associated with poor prognosis in colorectal 
cancer and glioma patients (Lin et al., 2009; Liou et al., 2010). Therefore, 
IGFBP2 appears to be an interesting candidate for closer study in the context of 
the glucose deprivation stress response. 
Following up on the results of the gene expression microarray, IGFBP2 
expression levels during glucose deprivation were examined further. RT-qPCR 
results demonstrate that in T-REx-293 cells incubated in glucose-free medium, 
IGFBP2 mRNA expression is unaltered after 3 h of incubation but is 
measurably decreased after 6 h, eventually declining to 5-fold below the 
complete medium level after 48 h. Similarly, in Vector-293 and TRIB3-293 
cells, IGFBP2 mRNA expression declines in response to glucose deprivation. 
Crucially, however, in TRIB3-293 cells suffering from glucose deficiency, the 
level of IGFBP2 mRNA is approximately 2-fold higher in Tet-treated cells 
compared to cells without Tet, verifying the microarray results. No effect of Tet 
on IGFBP2 expression is seen in Vector-293 cells, irrespective of glucose 
availability, or in complete medium-incubated TRIB3-293 cells. These effects 
are also present at the protein level, with Tet treatment resulting in enhanced 
IGFBP2 protein levels in TRIB3-293 cells—but not in Vector-293 cells—
during glucose deprivation. Thus, elevated TRIB3 expression alleviates the 
glucose starvation-induced downregulation of the IGFBP2 transcript and 
protein levels in HEK293 lineage cells. 
Other researchers have demonstrated that IGFBP2 expression inhibits cell 
death caused by genotoxic compounds (Migita et al., 2010; Myers et al., 2015; 
Zhu et al., 2015). To discover whether IGFBP2 expression can also regulate 
cell viability during glucose starvation, IGFBP2 silencing and overexpression 
experiments were performed in T-REx-293 cells. Transfection of the cells with 
siRNA targeting IGFBP2 resulted in the successful knockdown of IGFBP2 
expression, accompanied by an accelerated rate of cell death in response to 
glucose deprivation. Conversely, transfection of T-REx-293 cells with a human 
IGFBP2 expression plasmid enhanced cell viability in glucose-free medium. 
These results demonstrate that reduced expression of IGFBP2 aggravates cell 
death during glucose deprivation. 
Potentiating IGFBP2 expression could act as the mechanism by which 
TRIB3 defers glucose deprivation-induced cell death. To determine whether the 
pro-survival effect of TRIB3 during glucose starvation is mediated by IGFBP2, 
experiments incorporating the concurrent manipulation of TRIB3 and IGFBP2 
expression were carried out. Using TRIB3-293 cells, the effect of IGFBP2 
silencing on glucose-deprived cell viability was analyzed with and without Tet-
induced TRIB3 expression. This revealed that in cells with diminished IGFBP2 
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expression, increased expression of TRIB3 is unable to enhance survival. 
Complementing the previous experiment, the effect of concurrent and 
individual knockdown of TRIB3 and IGFBP2 on cell survival was examined in 
T-REx-293 cells. In addition to determining the incidence of cell death, visual 
changes in cell morphology were also monitored during the course of glucose 
starvation. The results show that simultaneously silencing TRIB3 and IGFBP2 
impairs cell viability to a similar degree as silencing either of the genes 
individually. In line with this, glucose deprivation-induced cell morphology 
deterioration, such as cell rounding and detachment from substrate, is markedly 
accelerated in cells with individual or concurrent TRIB3 and IGFBP2 
knockdown, compared to cells transfected with negative control siRNA only. 
Taken together, the results indicate that the cell viability-enhancing effect of 
TRIB3 is dependent on IGFBP2. 
Uncovering TRIB3 and IGFBP2 as positive modulators of glucose-deprived 
cell survival implicates them in the stress responses acting in ischemic tissues 
and poorly-vascularized regions of tumors, examples of nutrient-deficient 
microenvironments. For instance, colorectal, ovarian and breast tumors are 
known to overexpress both TRIB3 and IGFBP2 (Bowers et al., 2003; Busund et 
al., 2005; Mishra et al., 1998; Miyoshi et al., 2009; Wang et al., 2006; 
Wennemers et al., 2011a; Xu et al., 2007). Based on the results obtained from 
glucose-starved cells, the high TRIB3 levels in these tumors could contribute to 
the enhanced levels of IGFBP2 expression observed, which then could 
contribute towards cancer cell survival.  
How TRIB3 regulates IGFBP2 transcript abundance is currently unclear. 
Interestingly, glucose deprivation-regulated genes that are TRIB3-upregulated 
contain an overrepresentation of putative BCL6 binding sites, and IGFBP2 is 
one of the predicted BCL6 target genes. BCL6, which is a transcription 
repressor (Chang et al., 1996), has been found to form a complex with TRIB3 
(Miles et al., 2005). The functional significance of the interaction between 
TRIB3 and BCL6 has not been studied; it could be hypothesized that TRIB3 
binding to BCL6 acts to de-repress BCL6 target genes. How IGFBP2 asserts its 
cell viability-enhancing effect on glucose-starved cells also remains obscure at 
present. TRIB3 interacts with and prevents caspase-3 activation (Shimizu et al., 
2012), and IGFBP2 is also known to negatively regulate caspase-3 activity 
(Migita et al., 2010), suggesting a possible link that could be explored further. 
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5. CONCLUSIONS 
Based on a review of previous literature, TRIB3 is a mammalian gene that is 
transcriptionally induced in response to a variety of cellular stresses, including 
nutrient deprivation, oxidative stress and endoplasmic reticulum stress. In addi-
tion to promoter regulation, the control of TRIB3 gene expression is known to 
occur at the level of mRNA degradation, protein post-translational modification 
and protein degradation. Further, several variants of human TRIB3 mRNA have 
been described.  
The TRIB3 protein features a protein kinase domain with deviations in 
highly-conserved, catalytically important motifs. Therefore, TRIB3 is a 
‘pseudokinase’ that appears to lack marked enzymatic capability. TRIB3 is 
known to function by binding to specific proteins and affecting their activity, 
with the most common mode of action seen for TRIB3 being the inhibition of 
its interaction partner’s activity. For example, TRIB3 forms inhibitory protein–
protein interactions with ATF4, the central transcriptional regulator of the eIF2α 
phosphorylation pathway (also termed the integrated stress response), and Akt 
kinase, which is involved in glucose metabolism and cell survival. Notably, 
since ATF4 itself is a major transcriptional activator of TRIB3 in response to 
certain stresses, a negative feedback loop controlling ATF4 activity is formed in 
cell cultures subjected to stress.  
In all, nearly 30 different proteins have been reported to form interactions of 
known biological significance with TRIB3, including several transcription 
factors, protein kinases and ubiquitin ligases. Through these and potentially 
other interactions, TRIB3 participates in multiple intracellular signaling 
pathways and is involved in the cellular stress response and the determination of 
cell viability, glucose signaling and energy metabolism, inflammation, and cell 
differentiation. As a result, TRIB3 is implicated in several human diseases, 
notably cancer and type 2 diabetes. Nevertheless, much regarding TRIB3 
function remains unclear. Drawing upon the gaps in the current knowledge, 
several investigations into the regulation and role of TRIB3 were undertaken in 
the current work. 
 
The following conclusions can be drawn from the results of the experiments: 
 
 The TRIB3 mRNA population composition changes in response to stress: in 
HepG2 human hepatoma cells treated with arsenite, an inducer of oxidative stress, 
TRIB3 mRNA variants containing a truncated 5′-UTR become predominant, 
resulting in enhanced translational potential of the TRIB3 mRNA pool.  
 Trib3 expression is positively regulated by the growth factor IL-3 in 
BMMCs, mast cells derived in vitro from mouse bone marrow, and BMMCs 
generated from Trib3-deficient mice display impaired immunological 
functions (both degranulation and cytokine induction), implicating Trib3 in 
the modulation of the immune response. 
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 Trib3 expression increases during the course of mouse brain development, 
and mice with a lack of Trib3 exhibit enlarged lateral ventricles in the brain. 
In the adult mouse brain, Trib3 expression is constitutively high in the cere-
bellum and inducible in the anterior piriform cortex by the consumption of 
amino acid-deficient diet. However, Trib3 knockout mice display normal 
aversion to amino acid-imbalanced diet, as well as unaltered long-term 
spatial memory and fear memory, indicating that eIF2α–ATF4 pathway-
dependent cognitive functions are not altered by the absence of Trib3. 
 Endoplasmic reticulum stress-mediated ATF4 activation upregulates TRIB3 
transcription in glucose-deprived cells of the HEK293 lineage. Genome-
wide gene expression profiling revealed that TRIB3 mRNA ranks as the most 
highly glucose deprivation-regulated transcript after 24 h of glucose starva-
tion, and identified approximately 40 glucose deprivation-responsive genes 
that are affected by TRIB3 overexpression. Transcription factor motif enrich-
ment analysis uncovered that most TRIB3-inhibited genes are probable 
target genes of ATF4, a known TRIB3 binding partner. Additionally, TRIB3 
substantially alleviated the repression of IGFBP2 in glucose-deprived cells, 
which was shown to be a novel mechanism of deferring cell death caused by 
glucose deficiency. Thus, TRIB3 and IGFBP2 are potentially important for 
cell survival in nutrient-poor microenvironments such as tumors or infarction 
core regions. 
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SUMMARY IN ESTONIAN 
Imetajate pseudokinaasi TRIB3 funktsioonid ja regulatsioon 
TRIB3 on üks kolmest imetajates esinevast homoloogist äädikakärbse valgule 
Tribbles, mis avastati kui mitoosi inhibiitor kärbse varajases embrüonaalses 
arengus. Embrüotes, milles puudus funktsionaalne Tribbles valk, nähti 
gastrulatsiooni faasis rakkude pidurdamatut paljunemist, mistõttu nimetati geen 
ulmeseriaali „Star Trek“ tegelaste tribble’ite järgi, kellele on iseloomulik üli-
kiire arvukuse suurenemine.  
Tribbles perekonna valgud sisaldavad ühte selgesti tuvastatavat valgu-
domeeni, milleks on seriini/treoniini proteiinikinaasi domeen. Kuna aga mitmed 
selle domeeni katalüütiliselt olulised ja laialdaselt konserveerunud aminohappe-
jäägid on Tribbles valkudes asendunud, klassifitseeritakse Tribbles valgud 
pseudokinaasideks. Kokku on inimeses pseudokinaase ligikaudu kümme 
protsenti kõigist kinaasi domeeni sisaldavatest valkudest ning valgujärjestuste 
järgi paigutuvad pseudokinaasid paljudesse proteiinikinaaside alamklassidesse. 
Oluliste konserveerunud aminohappejääkide asendumine viitab sellele, et 
pseudokinaasid ei saa teostada kinaasi ensüümreaktsiooni klassikalise katalüüti-
lise mehhanismi vahendusel. Samas ei pruugi pseudokinaasid olla ensümaati-
lises mõttes täiesti inertsed; muuhulgas on ka TRIB3 puhul hiljuti leitud (väga) 
vähene autofosforüleerimise võime in vitro. 
Nii inimesel kui ka hiirel on TRIB3 mRNA ekspressioonitase kõrge maksas ning 
paljudes teistes organites ja kudedes on avaldumise tase mõõdukas. Tähelepanu-
väärne on, et TRIB3 ekspressioonitase tõuseb paljudes rakutüüpides vastusena 
mitmesugustele stressidele. Näiteks aktiveeritakse TRIB3 ekspressioon endo-
plasmiitilise retiikulumi (ER) stressi, asendamatu aminohappe puuduse, 
hapnikupuuduse ja oksüdatiivse stressi korral (kuid mitte genotoksilise stressi 
korral). On leitud, et stresside korral vahendab TRIB3 promooteri aktivatsiooni 
DNA element, mida nimetatakse C/EBP-ATF liitelemendiks, ning sinna seondub 
stressi korral transkriptsioonifaktor ATF4, moodustades heterodimeeri mõne 
C/EBP perekonna faktoriga (näiteks CHOP, C/EBPγ või C/EBPβ). Imetaja-
rakkudes toimub ühtse vastusena eritüübilistele stressidele translatsiooni 
initsiatsioonifaktori eIF2α fosforüleerimine, mis toob kaasa ATF4 translatsioonilise 
ülesreguleerimise – seeläbi on seletatav TRIB3 ekspressiooni käivitumine vastusena 
eritoimelistele stressoritele. Lisaks transkriptsiooni tasemele toimub TRIB3 
avaldumise reguleerimine veel ka mRNA stabiilsuse mõjutamise, post-
translatsiooniliste modifikatsioonide ja valgu eluea reguleerimise kaudu. 
TRIB3 valk asetseb rakutuumas ja tsütoplasmas ning ta funktsioneerib teiste 
valkudega seondumise kaudu. TRIB3 enamasti inhibeerib oma seondumis-
partneri aktiivsust, kuid mõnel juhul mõjutab ka partneri spetsiifikat. Praegu-
seks on selliseid TRIB3 interaktsioonipartnereid, mille puhul on interaktsioonile 
leitud ka mingisugune bioloogiline tähtsus, teada ligi 30 tükki. On tähelepanu-
väärne, et TRIB3 inhibeerib mitmeid transkriptsioonifaktoreid, mis tema enda 
avaldumistaset suurendavad, moodustades seega negatiivse tagasiside mehha-
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nisme (näiteks ATF4, CHOP, C/EBPβ ja NF-κB puhul). TRIB3 interakteerub 
veel ka mitmete kinaasidega (enim tähelepanu on pälvinud interaktsioon 
kinaasiga Akt), ubikvitiini ligaasidega ja muudesse klassidesse kuuluvate valku-
dega. Mitmed TRIB3 funktsioonid on seotud raku stressivastuse ja rakkude 
elulemuse reguleerimisega, näiteks stressivastuse transkriptsioonifaktorite 
ATF4, CHOP ja NF-κB inhibeerimine, rakkude elulemusega seotud kinaaside 
Akt ja MLK3 inhibeerimine ning kaspaas-3 aktiveerimise mõjutamine. See-
juures võib TRIB3 sõltuvalt stressi- ja rakutüübist avaldada elulemusele 
positiivset või negatiivset mõju. 
Hiired, kellel puuduvad mõlemad koopiad Trib3 geenist (Trib3−/− hiired), on 
eluvõimelised ja ei eristu väliselt metsiktüüpi (Trib3+/+) hiirtest. Rasvarikka 
söödaga toitmise korral on aga leitud, et Trib3−/− hiirtel on paranenud glükoosi 
ainevahetuse näitajad. Teisest küljest on Trib3 puudusega hiirtel suurenenud 
vastuvõtlikkus diabeedist tingitud neerupatoloogia tekkeks ja kiirenenud kasva-
jate areng mõnedes kasvajatekke mudelites. Lisaks on valmistatud ka trans-
geenseid hiiri, kellel on Trib3 teatud koes üleekspresseeritud, ning nende hiirte 
uurimisel saadud tulemused viitavad, et TRIB3 võib mõjutada kõhunäärme  
β-rakkude, rasvkoe ja lihaskoe toimimist. Inimeses on TRIB3 avaldumistase 
kõrgenenud erinevates pahaloomulistes kasvajates ning jämesoole, maksa ja 
kopsu kasvajate puhul on kõrgenenud TRIB3 tase seotud halvema prognoosiga. 
Lisaks vähkkasvajatele on TRIB3 inimeses palju tähelepanu pälvinud seoses  
2. tüüpi diabeediga ning sellega kaasnevate haigustega. Nimelt esineb inim-
populatsioonides TRIB3 alleel, millelt kodeeritavas valgus on 84. positsioonis 
glutamiinhappe jääk asendunud arginiini jäägiga, ja on leitud, et selle alleeli 
esinemine toob kaasa 2. tüüpi diabeeti haigestumise riski suurenemise. 
Varasemast on teada, et inimese TRIB3 geenilt toodetakse erinevaid mRNA 
isovorme, millel varieerub 5′-mittetransleeritav regioon, sest kasutatakse alter-
natiivseid variante esimesest eksonist ja alternatiivseid transkriptsiooni algus-
punkte. Käesoleva töö üheks eesmärgiks oli kirjeldada, milline on TRIB3 
mRNA-de populatsiooni isovormiline koosseis ja uurida, kas see muutub 
rakustressi tingimustes. Selle saavutamiseks töötati välja reaalaja PCR-il põhi-
nev uuringusüsteem, mis võimaldab omavahel võrrelda erinevate mRNA 
variantide arvukust. Süsteemi rakendati inimese hepatoomi rakuliini HepG2 
rakkudes, mida inkubeeriti eelnevalt kas tavatingimustel või arseniiti sisaldavas 
söötmes, mis põhjustab rakkudes oksüdatiivset stressi ja suurendab TRIB3 
mRNA avaldumistaset.  
Tulemustest selgub, et nii tavasöötmes kui ka arseniidistressi korral 
domineerib splaiss-variant 1A, moodustades ligikaudu 80% TRIB3 mRNA-dest, 
arvukuselt järgmine on 1B4 (ligikaudu 8%) ning variandid 1B1, 1B2 ja 1B3 on 
minoorsed (kokku ligikaudu 1%). Tähelepanuväärne on, et splaiss-variant 1A 
mRNA-de hulgas toimub vastusena stressile oluline muutus transkriptsiooni 
alguspunktide kasutamises: kui tavatingimustel kasvatatud rakkudes oli vaid 
ligikaudu 10% 1A mRNA-dest lühikese, C/EBP-ATF liitelementidest allavoolu 
algava 5′-liiderjärjestusega, siis arseniidiga töödeldud rakkudes oli selliste 
mRNA-de osakaal ligikaudu 80% splaiss-variant 1A mRNA-dest. Seega toimub 
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arseniidistressi korral TRIB3 mRNA avaldumistaseme tõus peamiselt lühikest 
5′-liiderjärjestust sisaldavate splaiss-variant 1A mRNA-de tootmise kaudu. 
Meie laboris D. Ördi poolt teostatud katsed näitavad, et valgu tootmine taolistelt 
mRNA-delt on efektiivsem ja seega toimivad stressi korral TRIB3 geeni-
ekspressiooni suurendamiseks nii transkriptsioonilised kui ka translatsioonilised 
mehhanismid. 
Nuumrakud on immuunrakud, mis paiknevad kudedes (näiteks nahas ja 
limaskestades) ja viivad ellu IgE-vahendatud immuunvastuseid, muuhulgas ka 
allergilisi reaktsioone. Antigeeniga kokkupuutel eritavad aktiveeritud nuum-
rakud põletikumediaatoreid, näiteks histamiini, prostaglandiine ja tsütokiine (sh 
TNF ja IL-6). Imetajates on Tribbles valkudel varasemalt leitud mõningaid 
seoseid vereloome protsessidega, näiteks TRIB3 puhul vere punaliblede 
moodustumisega ning TRIB1 ja TRIB2 puhul leukeemia tekkega, kuid nuum-
rakkude osas andmed puuduvad.  
Nuumrakkude eellased paiknevad luuüdis ning in vitro on nuumrakke 
võimalik hiire luuüdist toota, kasvatades luuüdi rakke kasvufaktori IL-3 
juuresolekul. Uurides taoliselt saadud primaarseid nuumrakukultuure, leiti käes-
olevas töös, et Trib3 on transkriptsioonilisel tasemel positiivselt reguleeritud 
nuumrakkude kasvufaktori IL-3 poolt. Võrdluseks, nuumrakkude ekspo-
neerimine IgE antikehale ja stimuleerimine antigeeniga avaldasid Trib3 
ekspressioonitasemele palju nõrgemat mõju. Järgnevalt loodi nuumraku-
kultuurid, milles puudus Trib3 geen, kasutades meie töögrupi poolt loodud 
Trib3 deletsiooniga hiireliini. Selgus, et Trib3 puudumine ei häiri nuumrakkude 
diferentseerumist IL-3 toimel in vitro, kuid Trib3−/− nuumrakkude immuno-
loogilises aktiivsuses avaldusid mitmed kõrvalekalded. Nimelt on antigeeniga 
stimuleeritud Trib3−/− nuumrakkudes oluliselt pärsitud nii põletikumediaatorite 
vabastamine graanulitest (degranulatsioon) kui ka tsütokiinide de novo sünteesi 
käivitamine, mis kujutavad endast kaht võrdlemisi eraldi toimuvat immunoloo-
gilise aktiivsuse faasi. Seega võib Trib3 osaleda immuunvastuste mõjutamises. 
In vivo katse uurimaks nuumrakkude degranulatsiooni hiire kõrva nahas ei 
näidanud erinevust Trib3+/+ ja Trib3−/− hiirte vahel, kuid kuna IL-3 mõjul luu-
üdist in vitro moodustunud nuumrakud meenutavad pigem limakestades 
paiknevaid nuumrakke kui naha nuumrakke, siis organismi tasemel võib Trib3 
puudumise mõju avalduda näiteks limaskestade nuumrakkudes või teistes 
nuumrakkude füsioloogilistes reaktsioonides peale degranulatsiooni, mille uuri-
misele teostatud katse peamiselt suunatud oli. 
Trib3 mRNA ja selle poolt kodeeritav valk avastati esmalt neuronaalsetes 
rakkudes ning ATF4 – TRIB3 poolt inhibeeritav stressivastuse transkript-
sioonifaktor – on kirjeldatud lisaks ka kui pikaajalise mälu vaigistaja. 
Seetõttu seati käesoleva töö üheks eesmärgiks selgitada Trib3 rolli peaajus. 
Esmalt uuriti Trib3 mRNA avaldumistaset hiire peaaju embrüonaalse arengu 
vältel ja leiti, et Trib3 ekspressioon ajus suureneb sujuvalt embrüonaalse 
arengu 14. päevast (E14) kuni 18. päevani (laborihiirte tiinus kestab 19–20 
päeva). Vahetult sündimise järel langeb Trib3 ekspressioonitase mõnevõrra, 
kuid taastub kolmandaks sündimisjärgseks päevaks, ületades E14 taset 
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selleks ajaks ligikaudu kuus korda. Seevastu Trib1 ja Trib2 avaldumis-
tasemed on peaaju arengu vältel suhteliselt stabiilsed ja ei ole muutunud ka 
juveniilsete Trib3−/− hiirte ajus.  
Morfoloogilised uuringud näitasid, et Trib3 puudusega hiirtel on peaaju 
ehitus üldjoontes normaalne, kuid avaldus trend, et Trib3−/− hiirtel on suuremad 
külgmised ajuvatsakesed. Täiendavad mõõtmised kinnitasid, et nii täiskasvanud 
kui ka juveniilsetel Trib3−/− hiirtel on külgmised ajuvatsakesed poolteist kuni 
kaks korda suuremad kui Trib3+/+ hiirtel. Seega võib Trib3 olla seotud aju-
vatsakeste arenguga. Inimese puhul on leitud, et ajuvatsakesed suurenevad 
vananemise ja neurodegeneratiivsete haiguste korral, kuid samas on 
ajuvatsakeste mõõtmed ka tervetel noortel inimestel suuresti varieeruvad.  
Kuna TRIB3 on rakustressi kontekstis kirjeldatud kui eIF2α-ATF4 raja 
tagasisideline inhibiitor ning seesama rada on seotud ka mitmete käitumuslike 
protsessidega, siis otsustati läbi viia Trib3 ekspressiooni uuringuid hiire peaaju 
erinevates osades ja teostada käitumiskatseid Trib3−/− hiirtega. Hiired on 
võimelised tunnetama teatud ajuregiooni, anterior piriform cortex-i (APC) abil 
asendamatute aminohapete ebatasakaalulist esinemist äsjatarbitud söödas ja 
piiravad sellise sööda tarbimist. Reaalaja PCR-i abil saadud tulemused näitavad, 
et tavatingimustel on Trib3 mRNA avaldumistase ligikaudu ühesugune suuraju 
frontaalkorteksis, hipokampuses ja APC-s ning märkimisväärselt kõrgem 
väikeajus (seevastu Trib1 ja Trib2 tasemed varieerusid uuritud ajuosade 
võrdluses vähe). Leutsiinivaba toidu tarbimise järel suurenes aga Trib3 
ekspressioon spetsiifiliselt APC-s. Hiirte toidutarbimise jälgimine näitas, et 
Trib3−/− hiirte vastumeelsus leutsiinivaba sööda tarbimisele on võrreldav 
Trib3+/+ hiirte omaga. Lisaks toidu aminohappelise koostise tunnetamisele 
osaleb eIF2α-ATF4 rada ajus veel pikaajalise ruumimälu ja hirmumälu 
toimimises. Vastavad käitumiskatsed aga näitasid, et Trib3−/− hiirtel ei ole 
muutunud ruumimälu, ruumimälu ümberõppimise võime ega auditoorne või 
kontekstuaalne hirmumälu. Seega ei ole TRIB3 valgul tõenäoliselt asendamatut 
rolli eIF2α-ATF4 raja aktiivsuse piiramisel peaajus käitumuslike protsesside 
raames, kuid Trib3 eripärane ekspressioonimuster ajus ja ajuvatsakeste suuruse 
fenotüüp Trib3−/− hiirtel viitavad, et TRIB3 võib täita ajus mõnda muud rolli. 
Glükoosipuudus, mis esineb näiteks tahkete kasvajate sisemuses ja infarkti-
kolletes, põhjustab rakkudes stressi ning võib kutsuda esile rakusurma. Käes-
olevas töös uuriti TRIB3 olulisust glükoosipuuduse stressivastusele, kasutades 
HEK293 rakkudest stabiilse transfektsiooni teel valmistatud rakuliine, mis 
võimaldavad rakendada tetratsükliini poolt aktiveeritavat geeniekspressiooni 
süsteemi.  
Reaalaja PCR-i abil saadud tulemused näitavad, et glükoosipuuduse korral 
tõuseb rakkudes TRIB3 mRNA avaldumistase kiiresti (alates 3 h) ja et TRIB3 
mRNA ülesregulatsioon tuleneb TRIB3 geeni transkriptsioonilisest aktivat-
sioonist. ATF4 vaigistamise katsed näitasid, et ATF4 on vajalik TRIB3 üles-
regulatsiooniks glükoosipuuduse korral. Täiendavad uuringud selgitasid välja, et 
ATF4 aktivatsioon (ja TRIB3 geeni ülesregulatsioon) glükoosipuuduse korral 
toimub ER stressi tõttu ja on vahendatud ER-seoselise eIF2α kinaasi PERK poolt.  
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D. Ördi poolt läbiviidud katsete põhjal toetab TRIB3 glükoosipuuduse 
tingimustes rakkude elulemust. Selgitamaks TRIB3 mõju glükoosipuuduse 
transkriptsioonilisele vastusele teostati ülegenoomne geeniekspressiooni 
analüüs. Glükoosipuuduse toimel oli muutunud sadade geenide ekspres-
sioonitase, kusjuures ülesreguleeritud geenide hulgas oli kõige tugevamalt 
üleesindatud geenide kategooriaks ER stressi vastuse geenid ja kõige tugeva-
malt üleesindatud transkriptsioonifaktori seondumismotiiviks oli C/EBP ja ATF 
transkriptsioonifaktorite ühendmotiiv. See viitab, et C/EBP ja ATF perekondade 
faktorid on olulised otsesed transkriptsioonilised aktivaatorid glükoosipuuduse 
vastuse korral. Selleks, et selgitada TRIB3 toimet glükoosipuuduse vastusele, 
vaadeldi TRIB3 üleekspressiooni mõju glükoosipuuduse poolt mõjutatud 
geenidele. Kokku tuvastati ligikaudu 40 TRIB3-tundlikku geeni. Analüüsides 
transkriptsioonifaktorite seondumismotiivide esinemist TRIB3 toimel allaregu-
leeritud geenides, selgus, et ATF4 inhibeerimine võib olla peamine mehhanism, 
mille kaudu TRIB3 geeniekspressiooni represseerib. Seevastu geenidel, mille 
ekspressioonitase suurenes TRIB3 toimel, ei avaldunud nii selget ühendavat 
mehhanismi.  
Glükoosipuuduse vastuse geen, mille ekspressioon TRIB3 toimel enim 
tõusis, oli IGFBP2. Täiendavad katsed kinnitasid, et IGFBP2 mRNA ja valgu 
tasemed langevad glükoosipuuduse korral ning et TRIB3 taseme tõstmine 
leevendab märkimisväärselt IGFBP2 taseme vähenemist glükoosipuuduse 
korral. IGFBP2 on kliinilises mõttes tähelepanuväärne geen, kuna selle 
üleekspressiooni on kirjeldatud paljudes inimese kasvajates ja mõnedes kasvaja-
tüüpides on IGFBP2 suurem avaldumistase ka kehvema prognoosi markeriks. 
Samas on võrdlemisi vähe teada IGFBP2 mõjust rakkude elulemusele. IGFBP2 
vaigistamise ja üleekspressiooni katsete abil õnnestus välja selgitada, et 
IGFBP2 avaldumistaseme langus glükoosipuuduse korral toetab rakkude sure-
mist, seega võib IGFBP2 hulga tõstmine olla mehhanism, mille kaudu TRIB3 
rakkude elulemust parandab. Järgnevad katsed, kus mõjutati üheaegselt 
IGFBP2 ja TRIB3 ekspressioonitasemeid, näitasid, et TRIB3 positiivne mõju 
rakkude elulemusele on tõepoolest sõltuv IGFBP2-st. Seega on TRIB3 ja 
IGFBP2 glükoosipuuduse all kannatavate rakkude elulemuse positiivsed mõju-
tajad, mis võivad mängida tähtsat rolli näiteks käärsoole, munasarja ja rinna 
vähkkasvajates, kus on kirjeldatud nii TRIB3 kui ka IGFBP2 üleekspressioon. 
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